Cardiology Today

Welcome to Cardiology Today – Recorded October 30, 2025. This episode summarizes 5 key cardiology studies on topics like lifestyle and statistical shape atlases. Key takeaway: Randomized Evidence for Atrial Fibrillation Success. Article Links: Article 1: Aggressive Risk Factor Reduction Study for Atrial Fibrillation Implications for Ablation Outcomes: The ARREST-AF Randomized Clinical Trial. (JAMA cardiology) Article 2: Cardiovascular disease-specific and all-cause mortality across socioeconomic status and lifestyles among patients with established cardiovascular disease in communities of China: data from a national population-based cohort. (Heart (British Cardiac Society)) Article 3: Prevalence, spectrum and aetiology of valvular heart disease based on community echocardiographic screening transition from different altitudes in Yunnan, China. (Heart (British Cardiac Society)) Article 4: Longitudinal cardiac imaging for assessment of myocardial injury in non-hospitalised community-dwelling individuals after COVID-19 infection: the Rotterdam Study. (Heart (British Cardiac Society)) Article 5: Relationship between left ventricular shape and cardiovascular risk factors: comparison between the Multi-Ethnic Study of Atherosclerosis and UK Biobank. (Heart (British Cardiac Society)) Full episode page: https://podcast.explainheart.com/podcast/randomized-evidence-for-atrial-fibrillation-success-10-30-25/ Featured Articles Article 1: Aggressive Risk Factor Reduction Study for Atrial Fibrillation Implications for Ablation Outcomes: The ARREST-AF Randomized Clinical Trial. Journal: JAMA cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41160038 Summary: The ARREST-AF Randomized Clinical Trial is an open-label, multicenter, randomized clinical trial with 12-month follow-up designed to determine the impact of risk factor and weight management on atrial fibrillation ablation rhythm outcomes. This study specifically addresses the need for randomized clinical trial evidence to support observational reports of reduced arrhythmia recurrence after atrial fibrillation ablation with aggressive lifestyle modification. By investigating this relationship, the ARREST-AF trial aims to establish whether lifestyle interventions can significantly improve the long-term success of atrial fibrillation ablation. This will provide crucial data for enhancing treatment strategies for patients with atrial fibrillation. Article 2: Cardiovascular disease-specific and all-cause mortality across socioeconomic status and lifestyles among patients with established cardiovascular disease in communities of China: data from a national population-based cohort. Journal: Heart (British Cardiac Society) PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40081938 Summary: This national population-based cohort study, conducted across 31 provinces in mainland China, investigated cardiovascular disease-specific and all-cause mortality among patients with established cardiovascular disease. Researchers included participants aged 35 to 75 years with self-reported diagnoses, collecting detailed information on socioeconomic status and lifestyle. The study aims to provide crucial evidence regarding socioeconomic status-related health inequality in cardiovascular disease patients who require both lifestyle changes and medical care, particularly in developing countries. This research will establish a clearer understanding of health disparities to inform targeted public health interventions. Article 3: Prevalence, spectrum and aetiology of valvular heart disease based on community echocardiographic screening transition from different altitudes in Yunnan, China. Journal: Heart (British Cardiac Society) PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40032496 Summary: This study investigated the prevalence, spectrum, and etiology of valvular heart disease across different altitudes in Yunnan Province, China, utilizing two sequential community-based echocardiography screening programs. The research addresses a gap in understanding how altitude may influence the cardiovascular system and contribute to geographical disparities in valvular heart disease epidemiology. By establishing these altitudinal differences, the study provides valuable insights into regional variations in disease burden and potential environmental factors influencing cardiac health. This contributes to a more comprehensive epidemiological understanding of valvular heart disease. Article 4: Longitudinal cardiac imaging for assessment of myocardial injury in non-hospitalised community-dwelling individuals after COVID-19 infection: the Rotterdam Study. Journal: Heart (British Cardiac Society) PubMed Link: https://pubmed.ncbi.nlm.nih.gov/39819621 Summary: The Rotterdam Study investigated myocardial injury in non-hospitalized community-dwelling individuals after C.O.V.I.D.-19 infection, also evaluating the relationship between persistent cardiac symptoms and myocardial function. This prospective population-base

Welcome to Cardiology Today – Recorded October 30, 2025. This episode summarizes 5 key cardiology studies on topics like nitric oxide and Familial hypercholesterolemia. Key takeaway: Early F.H. Diagnosis Via Newborn Blood Spots. Article Links: Article 1: Immediate or Deferred Nonculprit-Lesion PCI in Myocardial Infarction. (The New England journal of medicine) Article 2: PCI of Native Coronary Artery vs Saphenous Vein Graft After Prior Bypass Surgery: A Multicenter, Randomized Trial. (Journal of the American College of Cardiology) Article 3: Nuclear eNOS Interacts With and S-Nitrosates ADAR1 to Modulate Type I Interferon Signaling and Endothelial Function. (Circulation) Article 4: Geometric Features of Ventricular Tachycardia Corridors in Patients With Ischemic Cardiomyopathy. (Circulation) Article 5: Genetic Diagnosis of Familial Hypercholesterolemia in Residual Newborn Dried Blood Spots. (JAMA cardiology) Full episode page: https://podcast.explainheart.com/podcast/early-f-h-diagnosis-via-newborn-blood-spots-10-30-25/ Featured Articles Article 1: Immediate or Deferred Nonculprit-Lesion PCI in Myocardial Infarction. Journal: The New England journal of medicine PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41159879 Summary: This international, investigator-initiated, open-label, randomized controlled trial was designed to compare immediate percutaneous coronary intervention guided by instantaneous wave-free ratio with deferred percutaneous coronary intervention guided by cardiac stress magnetic resonance imaging. The study enrolled patients with S.T.-segment elevation myocardial infarction and multivessel disease. This research establishes a robust methodology to determine the optimal timing for treating nonculprit lesions in these high-risk patients. The findings from this trial will provide critical evidence to guide clinical practice for nonculprit-lesion management in S.T.-segment elevation myocardial infarction. Article 2: PCI of Native Coronary Artery vs Saphenous Vein Graft After Prior Bypass Surgery: A Multicenter, Randomized Trial. Journal: Journal of the American College of Cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41159978 Summary: The PROCTOR multicenter randomized trial was designed to compare clinical outcomes between percutaneous coronary intervention of the native coronary artery versus percutaneous coronary intervention of the saphenous vein graft. This study enrolled patients with prior coronary artery bypass grafting who presented with saphenous vein graft failure. This randomized comparison directly addresses a gap in current guidelines, which rely solely on observational data for recommendations regarding percutaneous coronary intervention strategy after bypass surgery. The findings will establish evidence-based guidance for optimal revascularization in this complex patient population. Article 3: Nuclear eNOS Interacts With and S-Nitrosates ADAR1 to Modulate Type I Interferon Signaling and Endothelial Function. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41159282 Summary: This research assessed the role of nuclear endothelial nitric oxide synthase and nitric oxide signaling for endothelial cell function. Using loss-of-function approaches, confocal microscopy, and biochemical analyses, the study found that endothelial nitric oxide synthase localized in the endothelial cell nucleus generates nitric oxide. This nuclear endothelial nitric oxide synthase interacts with and S-nitrosates Adenosine Deaminase, R.N.A.-Specific, 1, consequently modulating type I interferon signaling. These findings reveal a novel molecular mechanism through which nuclear endothelial nitric oxide synthase regulates vascular inflammation and endothelial homeostasis, offering new therapeutic avenues for endothelial dysfunction. Article 4: Geometric Features of Ventricular Tachycardia Corridors in Patients With Ischemic Cardiomyopathy. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41159251 Summary: This retrospective cohort study characterized the geometric features of viable corridors participating in ventricular tachycardia circuitry in ischemic cardiomyopathy. Researchers analyzed patients who underwent cardiovascular magnetic resonance imaging before their first ventricular tachycardia ablation. Applying a 3-dimensional hyperboloid model to viable corridors derived from late gadolinium enhanced cardiovascular magnetic resonance imaging, the study provided a precise geometric understanding of ventricular tachycardia circuitry. This detailed geometric mapping improves the understanding of ventricular tachycardia mechanisms, potentially leading to more targeted and effective ablation strategies for ischemic cardiomyopathy. Article 5: Genetic Diagnosis of Familial Hypercholesterolemia in Residual Newborn Dried Blood Spots. Journal: JAMA cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41160044 Summary: This cross-sectional study investigated the feasibility

Welcome to Cardiology Today – Recorded October 29, 2025. This episode summarizes 5 key cardiology studies on topics like large hemispheric infarction and lower-extremity peripheral vascular interventions. Key takeaway: COVID-19 Vaccine Effects on High-Risk Hearts. Article Links: Article 1: Procedural Volume and Outcomes in Lower-Extremity Peripheral Vascular Interventions: Insights From the NCDR Peripheral Vascular Intervention Registry. (Journal of the American Heart Association) Article 2: Safety and Feasibility of YC-6 in Patients With Large Hemispheric Infarction: A Randomized Clinical Trial. (Journal of the American Heart Association) Article 3: Association of Pancreas Volume With Adverse Clinical Outcomes. (Journal of the American Heart Association) Article 4: Treatment Response and Survival in Methamphetamine-Associated Pulmonary Arterial Hypertension. (Journal of the American Heart Association) Article 5: COVID-19 Vaccination and Cardiovascular Outcomes in Older Adults With Coronary Artery Disease and Heart Failure: Insights From a Large Propensity-Matched Cohort Study. (Journal of the American Heart Association) Full episode page: https://podcast.explainheart.com/podcast/covid-19-vaccine-effects-on-high-risk-hearts-10-29-25/ Featured Articles Article 1: Procedural Volume and Outcomes in Lower-Extremity Peripheral Vascular Interventions: Insights From the NCDR Peripheral Vascular Intervention Registry. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41147410 Summary: This study utilized the National Cardiovascular Data Registry Peripheral Vascular Intervention registry to investigate the relationship between hospital and operator procedural volume and in-hospital major adverse limb events and major adverse cardiovascular events following lower-extremity peripheral vascular interventions. It assessed data collected from April 1 2014 to December 31 2019 to better understand how provider experience influences patient safety and outcomes. This research establishes a clearer understanding of volume-outcome associations, which is crucial for standardizing care and potentially improving patient prognosis in peripheral artery disease management. Article 2: Safety and Feasibility of YC-6 in Patients With Large Hemispheric Infarction: A Randomized Clinical Trial. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41147407 Summary: This randomized, double-blind, placebo-controlled, proof-of-concept clinical trial investigated the safety and preliminary feasibility of YC-6, specifically 5alpha-androst-3beta56beta-triol for injection, in patients experiencing large hemispheric infarction. The study enrolled individuals with middle cerebral artery infarction within 12 hours of symptom onset, addressing the urgent need for novel neuroprotective agents to combat malignant cerebral edema. By assessing these initial parameters, the research lays foundational groundwork for future therapeutic development, aiming to improve outcomes for a critical cause of poor prognosis in severe stroke. Article 3: Association of Pancreas Volume With Adverse Clinical Outcomes. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41147404 Summary: This study investigated the association of pancreas volume with adverse clinical outcomes, recognizing that chronic diseases can reduce pancreas size and impact endocrine and exocrine function. Researchers estimated baseline age-adjusted predicted pancreas volume using abdominal magnetic resonance imaging data from 36592 U.K. Biobank participants. The analysis establishes a critical understanding of whether reduced pancreas volume serves as an indicator for heightened risk of various adverse clinical conditions. This research contributes a significant marker for potentially identifying individuals at higher risk, enabling earlier monitoring or preventive strategies. Article 4: Treatment Response and Survival in Methamphetamine-Associated Pulmonary Arterial Hypertension. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41147399 Summary: This study aimed to elucidate treatment response and survival in Methamphetamine-associated Pulmonary Arterial Hypertension, a growing subset of pulmonary arterial hypertension. Researchers conducted a prospective protocolized cohort analysis of 138 incident patients, comparing 64 individuals with Methamphetamine-associated Pulmonary Arterial Hypertension to 74 with idiopathic Pulmonary Arterial Hypertension. The investigation focused on evaluating survival, response to continuous prostacyclin therapy, and right ventricle function in similarly treated cohorts. This research provides crucial data to distinguish outcomes and optimize therapeutic approaches for patients with Methamphetamine-associated Pulmonary Arterial Hypertension compared to idiopathic Pulmonary Arterial Hypertensi

Welcome to Cardiology Today – Recorded October 29, 2025. This episode summarizes 5 key cardiology studies on topics like M.I.N.O.C.A. and multiomics. Key takeaway: A.E.D. Training Boosts Cardiac Arrest Survival.. Article Links: Article 1: Stratified treatment of myocardial infarction with non-obstructive coronary arteries: the PROMISE trial. (European heart journal) Article 2: Adaptation of right ventricular function following tricuspid transcatheter edge-to-edge repair. (ESC heart failure) Article 3: Improved Survival With Automated External Defibrillator-Only Training in a Public-Access Defibrillation Program: A 23-Year Database Analysis of Progetto Vita. (Journal of the American Heart Association) Article 4: A Multiomics Approach to Defining Target-Organ Injury in Youths With Primary Hypertension: The SHIP AHOY Cohort. (Journal of the American Heart Association) Article 5: GATA2 Mediates Macrophage Proliferation During Atherosclerosis. (Journal of the American Heart Association) Full episode page: https://podcast.explainheart.com/podcast/a-e-d-training-boosts-cardiac-arrest-survival-10-29-25/ Featured Articles Article 1: Stratified treatment of myocardial infarction with non-obstructive coronary arteries: the PROMISE trial. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41150941 Summary: The P.R.O.M.I.S.E. trial is a multicenter randomized study designed to evaluate the optimal management strategy for myocardial infarction with non-obstructive coronary arteries, or M.I.N.O.C.A. This condition is associated with significant mortality, rehospitalization, and angina burden, yet no prior randomized clinical trials had assessed its treatment. The trial’s objective is to determine if a stratified treatment approach improves clinical outcomes for M.I.N.O.C.A. patients compared to standard care. This research establishes a crucial framework to guide future clinical practice for this high-risk patient population. Article 2: Adaptation of right ventricular function following tricuspid transcatheter edge-to-edge repair. Journal: ESC heart failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41147662 Summary: This study characterized changes in right ventricular ejection fraction, or R.V.E.F., following tricuspid transcatheter edge-to-edge repair, or T-T.E.E.R. Patients with significant tricuspid regurgitation underwent T-T.E.E.R. and cardiac magnetic resonance, or C.M.R., imaging, with follow-up C.M.R. performed within one to three months. The research aimed to clarify the impact of T-T.E.E.R. on right ventricular remodeling and its prognostic implications. By classifying patients based on postprocedural R.V. data, this work provides a clearer understanding of right ventricular adaptation after T-T.E.E.R., which is vital for assessing patient outcomes. Article 3: Improved Survival With Automated External Defibrillator-Only Training in a Public-Access Defibrillation Program: A 23-Year Database Analysis of Progetto Vita. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41147502 Summary: This 23-year database analysis of the Progetto Vita, or P.V., program in Piacenza demonstrates improved survival for out-of-hospital cardiac arrest, or O.H.C.A., using automated external defibrillator, or A.E.D.,-only training. The P.V. project pioneered the first community-based A.E.D. program in Europe, and this extensive analysis provides critical survival data. The study highlights that early defibrillation is crucial for managing fatal arrhythmias, and A.E.D. use effectively minimizes time to defibrillation. This finding underscores the significant public health benefit of simplified A.E.D.-only training in public-access defibrillation programs for enhancing O.H.C.A. survival. Article 4: A Multiomics Approach to Defining Target-Organ Injury in Youths With Primary Hypertension: The SHIP AHOY Cohort. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41147417 Summary: This study utilized a multiomics approach within the S.H.I.P. A.H.O.Y. cohort to define early cardiovascular target-organ injury in youths with primary hypertension. It included 132 individuals, with a mean age of 15.8 years, who were stratified by blood pressure and left ventricular mass index, or L.V.M.I. The research provides a unique opportunity to explore early cardiovascular damage in an age group largely free of confounding adult comorbidities. This approach is crucial for identifying early biomarkers and intervention points to prevent the progression of hypertension into adult cardiovascular disease. Article 5: GATA2 Mediates Macrophage Proliferation During Atherosclerosis. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41147413 Summary: This research identified that G.A.T.A.2 mediates macrophage proliferation during atherosclerosis, clarifying a key mechanism behind lesion development.

Welcome to Cardiology Today – Recorded October 28, 2025. This episode summarizes 5 key cardiology studies on topics like cardiac fibrosis and neurodevelopmental outcomes. Key takeaway: Nup35 Controls Heart Remodeling. Article Links: Article 1: Neurodevelopmental Outcomes in Early Adolescence: The Pediatric Heart Network’s Single Ventricle Reconstruction Trial. (Circulation) Article 2: Effect of Remote Ischemic Preconditioning on Myocardial Injury in Noncardiac Surgery: The PRINCE Randomized Clinical Trial. (Circulation) Article 3: The Role of the Collateral Circulation in Stable Angina: An Invasive Placebo-Controlled Study. (Circulation) Article 4: Cardiomyocyte Nucleoporin 35 regulates pathological cardiac remodeling through Wif1. (Cardiovascular research) Article 5: New insights into foam cells in atherosclerosis. (Cardiovascular research) Full episode page: https://podcast.explainheart.com/podcast/nup35-controls-heart-remodeling-10-28-25/ Featured Articles Article 1: Neurodevelopmental Outcomes in Early Adolescence: The Pediatric Heart Network’s Single Ventricle Reconstruction Trial. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40671650 Summary: This study from the Pediatric Heart Network’s S.V.R. I.I.I. trial evaluated neurodevelopmental and functional outcomes in early adolescence for survivors of hypoplastic left heart syndrome. It enrolled adolescents who were randomized to different surgical shunt types during the Norwood procedure as neonates, conducting multifaceted in-person assessments. The research provides critical long-term follow-up data on the impact of initial surgical approaches on these significant morbidities. This comprehensive evaluation is crucial for informing care strategies and improving long-term quality of life for this vulnerable patient population. Article 2: Effect of Remote Ischemic Preconditioning on Myocardial Injury in Noncardiac Surgery: The PRINCE Randomized Clinical Trial. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40511609 Summary: The multinational P.R.I.N.C.E. randomized clinical trial investigated the effect of remote ischemic preconditioning on myocardial injury during noncardiac surgery. Adult high-risk patients were randomly assigned to receive either remote ischemic preconditioning, involving three five-minute cycles of upper limb ischemia, or sham treatment after anesthesia induction. This robust, double-blind study aimed to definitively determine if remote ischemic preconditioning decreases postoperative myocardial injury and other complications. The trial establishes crucial evidence regarding the utility of remote ischemic preconditioning in improving outcomes for patients undergoing major noncardiac surgical procedures. Article 3: The Role of the Collateral Circulation in Stable Angina: An Invasive Placebo-Controlled Study. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41144984 Summary: This n-of-one invasive placebo-controlled study explored the relationship between myocardial ischemia, collateral circulation, and angina symptoms in stable coronary artery disease. Fifty-one participants with severe single-vessel coronary artery disease and angina were recruited for this investigation. The research aimed to clarify why the burden of ischemia often shows little correlation with angina severity and to explore the association between progressive collateral recruitment and ischemic preconditioning. This study provides a detailed understanding of the collateral circulation’s role in modulating symptoms and offering ischemic protection in stable angina patients. Article 4: Cardiomyocyte Nucleoporin 35 regulates pathological cardiac remodeling through Wif1. Journal: Cardiovascular research PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41145234 Summary: This research identified Cardiomyocyte Nucleoporin 35 as a key regulator of pathological cardiac remodeling. The study demonstrated that cardiac Nucleoporin 35 expression is significantly down-regulated during Angiotensin I.I.- and transverse aortic constriction-induced remodeling in mice. Cardiac-specific Nucleoporin 35 knockout mice displayed severe cardiac fibrosis, hypertrophy, and cardiac dysfunction, while its overexpression mitigated these pathologies by modulating Wif1. This discovery reveals a crucial mechanistic pathway underlying cardiac remodeling and presents a promising therapeutic target for heart disease. Article 5: New insights into foam cells in atherosclerosis. Journal: Cardiovascular research PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41144636 Summary: This comprehensive review advanced understanding of cholesterol-containing foam cells, which drive atherosclerosis and related cardiovascular events. It detailed how excessive foam cell accumulation leads to apoptosis, necrosis, necrotic core formation, and plaque destabilization. The review highlighted the persistent challenges in developing effective targete

Welcome to Cardiology Today – Recorded October 28, 2025. This episode summarizes 5 key cardiology studies on topics like PARTNER 3 trial and ESPRIT trial. Key takeaway: PREVENT Equations Refine Blood Pressure Control.. Article Links: Article 1: Transcatheter or Surgical Aortic-Valve Replacement in Low-Risk Patients at 7 Years. (The New England journal of medicine) Article 2: Using PREVENT Equations to Compare Intensive vs Standard Systolic Blood Pressure Control for Primary Prevention in SPRINT. (Journal of the American College of Cardiology) Article 3: Effect of Intensive Blood Pressure Control on Stroke: A Prespecified Secondary Analysis of the ESPRIT Trial. (Journal of the American College of Cardiology) Article 4: Clinical Practice of Surgical Treatment for Left-Sided Infective Endocarditis: Nationwide Data from the NIDUS Registry. (Circulation) Article 5: Long-Term Outcomes of Early Surgery Versus Conventional Treatment for Asymptomatic Severe Mitral Regurgitation: A Propensity Analysis. (Circulation) Full episode page: https://podcast.explainheart.com/podcast/prevent-equations-refine-blood-pressure-control-10-28-25/ Featured Articles Article 1: Transcatheter or Surgical Aortic-Valve Replacement in Low-Risk Patients at 7 Years. Journal: The New England journal of medicine PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41144631 Summary: This study from the PARTNER 3 trial aimed to provide longer-term clinical outcomes and valve durability assessments up to 7 years for low-risk patients with severe, symptomatic aortic stenosis. Patients were randomly assigned in a 1:1 ratio to undergo either transfemoral transcatheter aortic-valve replacement (T.A.V.R.) or surgical aortic-valve replacement. Prior 5-year data from this trial demonstrated similar outcomes between the two procedures. The research underscores the importance of continued long-term evaluation for valve durability and clinical effectiveness in these patients. Article 2: Using PREVENT Equations to Compare Intensive vs Standard Systolic Blood Pressure Control for Primary Prevention in SPRINT. Journal: Journal of the American College of Cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41125318 Summary: This secondary analysis of the SPRINT trial aimed to quantify the relative and absolute benefits and harms of intensive versus standard systolic blood pressure (S.B.P.) treatment using the new Predicting Risk of Cardiovascular Disease Events (PREVENT) equations. The PREVENT equations provide enhanced risk stratification by integrating estimated glomerular filtration rate, omitting race, and encompassing total cardiovascular disease events including heart failure. This research established a method for more precisely comparing intensive versus standard S.B.P. control by varying cardiovascular risk levels. The study demonstrates the utility of the PREVENT equations in refining primary prevention strategies for cardiovascular disease. Article 3: Effect of Intensive Blood Pressure Control on Stroke: A Prespecified Secondary Analysis of the ESPRIT Trial. Journal: Journal of the American College of Cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40864014 Summary: This prespecified secondary analysis of the ESPRIT trial evaluated the effects of intensive blood pressure control on stroke outcomes. Hypertensive patients with elevated cardiovascular risk were randomized to either intensive treatment, targeting systolic blood pressure (S.B.P.) below 120 millimeters of mercury, or standard treatment, aiming for S.B.P. below 140 millimeters of mercury. The study investigated the comparative impact of these two blood pressure management strategies on preventing stroke. This research highlights the critical role of S.B.P. reduction in stroke prevention, providing a focused comparison of intensive versus standard therapeutic approaches. Article 4: Clinical Practice of Surgical Treatment for Left-Sided Infective Endocarditis: Nationwide Data from the NIDUS Registry. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40836922 Summary: This observational cohort study utilized nationwide data from the NIDUS Registry to describe the clinical practice of surgical treatment for left-sided infective endocarditis (I.E.). The research specifically aimed to detail the utilization of surgery based on established indications and to assess associated mortality rates in this patient population. By examining a broad national cohort, this study overcomes limitations of prior research from selected tertiary centers, providing a more representative picture of real-world surgical approaches. This comprehensive analysis establishes a valuable benchmark for understanding current surgical interventions and outcomes in left-sided I.E. Article 5: Long-Term Outcomes of Early Surgery Versus Conventional Treatment for Asymptomatic Severe Mitral Regurgitation: A Propensity Analysis. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40799133 Summary:

Welcome to Cardiology Today – Recorded October 27, 2025. This episode summarizes 5 key cardiology studies on topics like cardiovascular outcomes and N.R.4.A.2. Key takeaway: Targeting P2Y14R Prevents Venous Thrombosis. Article Links: Article 1: Short-Term Anticoagulation versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure: The ANDES Randomized Clinical Trial. (Circulation) Article 2: Targeting P2Y14R alleviates platelet-induced NET formation and venous thrombosis through PKA/AKAP13/RhoA axis. (European heart journal) Article 3: Role of Stress-Responsive NR4A2 in Aldosterone-Producing Cell Cluster Formation. (Hypertension (Dallas, Tex. : 1979)) Article 4: Treating Malignant Hypertension With the Low-Sodium, Low-Protein, and Low-Fat Rice Diet. (Hypertension (Dallas, Tex. : 1979)) Article 5: Estrogen Influences Human Microvascular Endothelial Function Via Sex-Specific Regulation of Sphingolipids. (JACC. Basic to translational science) Full episode page: https://podcast.explainheart.com/podcast/targeting-p2y14r-prevents-venous-thrombosis-10-27-25/ Featured Articles Article 1: Short-Term Anticoagulation versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure: The ANDES Randomized Clinical Trial. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41139402 Summary: The A.N.D.E.S. Randomized Clinical Trial prospectively compared antithrombotic strategies after transcatheter left atrial appendage closure for patients with non-valvular atrial fibrillation. This multicenter international study randomized patients to either anticoagulation or dual antiplatelet therapy to determine the optimal approach for preventing device-related thrombosis. The trial’s objective was to establish which treatment strategy more effectively mitigates device-related thrombosis post-procedure. This research provides crucial evidence to guide clinical practice, potentially improving patient safety and outcomes following left atrial appendage closure. Article 2: Targeting P2Y14R alleviates platelet-induced NET formation and venous thrombosis through PKA/AKAP13/RhoA axis. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41143464 Summary: This study investigated the role of the P2Y14 receptor, highly expressed on neutrophils, in venous thromboembolism. Researchers discovered that the P2Y14 receptor mediates neutrophil extracellular trap formation, which exacerbates thrombo-inflammatory responses and venous thromboembolism. Critically, targeting the P2Y14 receptor successfully alleviated platelet-induced neutrophil extracellular trap formation and venous thrombosis by modulating the P.K.A. / A.K.A.P.13 / R.h.o.A. axis. These findings establish the P2Y14 receptor as a promising therapeutic target for developing new strategies to combat venous thromboembolism. Article 3: Role of Stress-Responsive NR4A2 in Aldosterone-Producing Cell Cluster Formation. Journal: Hypertension (Dallas, Tex. : 1979) PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41140167 Summary: This study investigated the mechanisms driving aldosterone-producing cell cluster formation, which are frequently observed in primary aldosteronism. Researchers utilized an integrated analysis of spatial transcriptomics and single-cell ribonucleic acid sequencing on aldosterone-producing cell clusters, aldosterone-producing adenomas, and zona glomerulosa cells. The study aimed to elucidate the role of the stress-responsive N.R.4.A.2 gene in this process. Establishing a clearer understanding of these mechanisms provides a foundational basis for developing new diagnostic and therapeutic strategies for primary aldosteronism and related hypertension. Article 4: Treating Malignant Hypertension With the Low-Sodium, Low-Protein, and Low-Fat Rice Diet. Journal: Hypertension (Dallas, Tex. : 1979) PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41140152 Summary: This retrospective study analyzed the efficacy of the rice diet, a very low-sodium, low-protein, and low-fat regimen, in treating malignant hypertension from the 1940s. Researchers identified 544 malignant hypertension patients from 17487 historical charts to assess factors associated with blood pressure reduction, including dietary adherence. The study established that this strict dietary intervention effectively reduced blood pressure in a significant cohort of patients before modern antihypertensive drugs were available. This analysis highlights the profound impact of dietary modifications on managing severe hypertension and provides historical context for lifestyle-based blood pressure management. Article 5: Estrogen Influences Human Microvascular Endothelial Function Via Sex-Specific Regulation of Sphingolipids. Journal: JACC. Basic to translational science PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41139325 Summary: This translational study demonstrated that sphingolipids are a critical compo

Welcome to Cardiology Today – Recorded October 27, 2025. This episode summarizes 5 key cardiology studies on topics like melanocortin receptor accessory protein 2 and transcatheter heart valve. Key takeaway: Tirzepatide Stops Chemo Heart Damage. Article Links: Article 1: Loss of melanocortin receptor accessory protein 2 in melanocortin-4 receptor neurons protect from obesity-associated autonomic and cardiovascular dysfunctions. (Cardiovascular research) Article 2: Tirzepatide alleviates doxorubicin-induced cardiotoxicity via inhibiting HRD1-mediated Nrf2 ubiquitination. (Cardiovascular research) Article 3: Insights Into Early Adoption and Physician Learning Curve of Pulsed Field Ablation in the United States. (Circulation. Arrhythmia and electrophysiology) Article 4: Impact of Pullback Pressure Gradient on Clinical Outcomes after Percutaneous Coronary Interventions. (Circulation. Cardiovascular interventions) Article 5: Five-Year Clinical Outcomes and Durability of a Self-Expanding Transcatheter Heart Valve With Intra-Annular Leaflets. (Circulation. Cardiovascular interventions) Full episode page: https://podcast.explainheart.com/podcast/tirzepatide-stops-chemo-heart-damage-10-27-25/ Featured Articles Article 1: Loss of melanocortin receptor accessory protein 2 in melanocortin-4 receptor neurons protect from obesity-associated autonomic and cardiovascular dysfunctions. Journal: Cardiovascular research PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40244925 Summary: This study investigated the role of melanocortin receptor accessory protein 2, or M.R.A.P.2, in melanocortin-4 receptor, or M.C.4.R., neurons regarding metabolic, autonomic, and cardiovascular functions. Researchers selectively deleted M.R.A.P.2 in M.C.4.R. neurons, finding that while this caused obesity and impaired glucose homeostasis, it also surprisingly protected against obesity-associated autonomic and cardiovascular dysfunctions. This research identifies M.R.A.P.2 in M.C.4.R. neurons as a significant regulator, offering a potential therapeutic target to decouple obesity from its cardiovascular complications. Article 2: Tirzepatide alleviates doxorubicin-induced cardiotoxicity via inhibiting HRD1-mediated Nrf2 ubiquitination. Journal: Cardiovascular research PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40036855 Summary: This study investigated how tirzepatide, a gastric inhibitory polypeptide / glucagon-like peptide-1 receptor agonist, mitigates doxorubicin-induced cardiotoxicity, a major limitation in cancer therapy. Researchers discovered that tirzepatide effectively alleviates cardiotoxicity by inhibiting H.R.D.1-mediated nuclear factor erythroid 2-related factor 2, or N.R.F.2, ubiquitination, providing a crucial mechanistic understanding. This finding establishes tirzepatide as a promising pharmacological candidate to prevent or treat life-threatening cardiac damage from doxorubicin. Article 3: Insights Into Early Adoption and Physician Learning Curve of Pulsed Field Ablation in the United States. Journal: Circulation. Arrhythmia and electrophysiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41133296 Summary: This study, the D.I.S.R.U.P.T.-A.F. registry, described the early adoption and physician learning curve of pulsed field ablation, or P.F.A., for atrial fibrillation in the United States. It prospectively evaluated acute procedural efficiency, safety outcomes, and clinical workflow patterns for both paroxysmal and nonparoxysmal atrial fibrillation cases. This research provides essential real-world data on the initial U.S. experience with P.F.A., establishing baselines for its application and informing future training and optimization strategies. Article 4: Impact of Pullback Pressure Gradient on Clinical Outcomes after Percutaneous Coronary Interventions. Journal: Circulation. Cardiovascular interventions PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41137850 Summary: This post-hoc analysis of the P.P.G. Global study aimed to evaluate the prognostic performance of the pullback pressure gradient, or P.P.G., model for predicting post-percutaneous coronary intervention, or P.C.I., fractional flow reserve, or F.F.R. Researchers investigated whether predicted physiological outcomes following P.C.I. influence clinical outcomes. This study established P.P.G. as a valuable physiological metric that differentiates focal from diffuse coronary artery disease and improves prediction of post-P.C.I. F.F.R., offering a potential tool to optimize intervention strategies. Article 5: Five-Year Clinical Outcomes and Durability of a Self-Expanding Transcatheter Heart Valve With Intra-Annular Leaflets. Journal: Circulation. Cardiovascular interventions PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41133305 Summary: This study aimed to describe the 5-year clinical outcomes and durability of the Portico self-expanding transcatheter heart valve with intra-annular leaflets. Researchers harmonized patient-level data from three prospective studies, utilizing

Welcome to Cardiology Today – Recorded October 27, 2025. This episode summarizes 5 key cardiology studies on topics like hypertensive disorders of pregnancy and pathogenic variant. Key takeaway: Trimetazidine for Early Hypertrophic Cardiomyopathy. Article Links: Article 1: Recaticimab in adult heterozygous familial hypercholesterolaemia (REMAIN-3): a multicentre, randomized, double-blind, placebo-controlled Phase 3 study. (Cardiovascular research) Article 2: Effects of iron deficiency anaemia on maternal haemodynamics and cardiac function in pregnant spontaneously hypertensive rats. (Cardiovascular research) Article 3: The pioneer factor, ETV2, regulates networks to specify the embryonic endothelial lineage. (Cardiovascular research) Article 4: YY1 regulates vascular resistance and blood pressure dynamics through epigenetic control of m6A RNA modifications in vascular smooth muscle cells. (Cardiovascular research) Article 5: Effect of trimetazidine dihydrochloride therapy on myocardial external efficiency in pre-clinical individuals with a hypertrophic cardiomyopathy pathogenic variant: results of the ENERGY trial. (Cardiovascular research) Full episode page: https://podcast.explainheart.com/podcast/trimetazidine-for-early-hypertrophic-cardiomyopathy-10-27-25/ Featured Articles Article 1: Recaticimab in adult heterozygous familial hypercholesterolaemia (REMAIN-3): a multicentre, randomized, double-blind, placebo-controlled Phase 3 study. Journal: Cardiovascular research PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40911402 Summary: The REMA.I.N.-3 study was a multicenter, randomized, double-blind, placebo-controlled Phase 3 trial. It assessed the efficacy and safety of recaticimab, a new humanized anti-Proprotein Convertase Subtilisin/Kexin type 9 antibody. This drug targets reduction of low-density lipoprotein cholesterol levels in adults with poorly controlled heterozygous familial hypercholesterolaemia. This research provides crucial data regarding a potential new therapeutic agent for this genetic disorder. Article 2: Effects of iron deficiency anaemia on maternal haemodynamics and cardiac function in pregnant spontaneously hypertensive rats. Journal: Cardiovascular research PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40878014 Summary: This study investigated the effects of iron deficiency anemia on maternal hemodynamics and cardiac function during pregnancy. Researchers utilized pregnant spontaneously hypertensive rats and normotensive controls to understand how iron deficiency interacts with hypertensive disorders of pregnancy. This research is critical for determining whether iron deficiency ameliorates or exacerbates maternal cardiovascular dysfunction in these high-risk pregnancies. Establishing this relationship could inform better management strategies for pregnant patients. Article 3: The pioneer factor, ETV2, regulates networks to specify the embryonic endothelial lineage. Journal: Cardiovascular research PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40832854 Summary: This study elucidated the role of E.T.V.2, a pioneer transcription factor, in specifying the embryonic endothelial lineage. Researchers uncovered the specific transcriptional and epigenetic changes orchestrated by E.T.V.2 to promote hematoendothelial lineage development. Concurrently, E.T.V.2 was shown to suppress other mesodermal cell fates, precisely directing differentiation. This fundamental research significantly advances our understanding of cardiovascular development and lineage specification, offering potential avenues for regenerative strategies. Article 4: YY1 regulates vascular resistance and blood pressure dynamics through epigenetic control of m6A RNA modifications in vascular smooth muscle cells. Journal: Cardiovascular research PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40795179 Summary: modifications in vascular smooth muscle cells. This study established that the transcription factor Y.Y.1 directly regulates vascular resistance and blood pressure dynamics. Researchers demonstrated that Y.Y.1 achieves this control through epigenetic modulation of m6A R.N.A. modifications within vascular smooth muscle cells. This work confirms Y.Y.1’s direct role in vasoreactivity, extending previous genome-wide association study findings. These discoveries provide crucial understanding of blood pressure regulation and open new avenues for therapeutic intervention in hypertension. Article 5: Effect of trimetazidine dihydrochloride therapy on myocardial external efficiency in pre-clinical individuals with a hypertrophic cardiomyopathy pathogenic variant: results of the ENERGY trial. Journal: Cardiovascular research PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40601822 Summary: The E.N.E.R.G.Y. trial investigated whether trimetazidine dihydrochloride therapy corrects reduced myocardial external efficiency in individuals carrying a hypertrophic cardiomyopathy pathogenic variant. This double-blind, placebo-controlled study focus

Welcome to Cardiology Today – Recorded October 26, 2025. This episode summarizes 5 key cardiology studies on topics like severe tricuspid regurgitation and cardiac implantable electronic devices. Key takeaway: T-TEER Safe in CIED Patients with Tricuspid Regurgitation. Article Links: Article 1: Left Atrial Appendage Occlusion Using a Novel System: Preclinical Evaluation and First-in-Human Experience. (JACC. Cardiovascular interventions) Article 2: Impact of Valve Frame Height on PCI Outcomes After TAVR. (JACC. Cardiovascular interventions) Article 3: Tricuspid Valve Transcatheter Edge-to-Edge Repair in Patients With Cardiac Implantable Electronic Devices: Insights From EuroTR. (JACC. Cardiovascular interventions) Article 4: Transcatheter Tricuspid Valve Replacement and CLEFT After Tricuspid TEER. (JACC. Cardiovascular interventions) Article 5: Comparative Outcomes of Intracardiac vs Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion: Insights From EMERGE LAA Postapproval Study. (JACC. Cardiovascular interventions) Full episode page: https://podcast.explainheart.com/podcast/t-teer-safe-in-cied-patients-with-tricuspid-regurgitation-10-26-25/ Featured Articles Article 1: Left Atrial Appendage Occlusion Using a Novel System: Preclinical Evaluation and First-in-Human Experience. Journal: JACC. Cardiovascular interventions PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41137840 Summary: This study evaluated the safety and performance of the novel Zenith Left Atrial Appendage occlusion system through preclinical canine models and a prospective first-in-human experience. The research successfully established the system’s safety and effectiveness for occluding the left atrial appendage. This represents a significant advancement, offering a new percutaneous option for stroke prevention in patients with atrial fibrillation who are intolerant to long-term oral anticoagulation. The Zenith system aims to overcome limitations of current devices like device-related thrombus and peridevice leak. Article 2: Impact of Valve Frame Height on PCI Outcomes After TAVR. Journal: JACC. Cardiovascular interventions PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41137839 Summary: Outcomes After T.A.V.R. This multicenter registry study evaluated the impact of bioprosthetic aortic valve type on long-term clinical outcomes for patients undergoing percutaneous coronary intervention following transcatheter aortic valve replacement. Researchers utilized data from the R.E.V.I.V.A.L.-P.C.I. registry across 21 European centers. The findings provide crucial clarity regarding the challenges of coronary access after transcatheter aortic valve replacement, particularly with tall-framed valves. This research has significant clinical implications for informing valve selection during transcatheter aortic valve replacement to optimize future coronary revascularization strategies. Article 3: Tricuspid Valve Transcatheter Edge-to-Edge Repair in Patients With Cardiac Implantable Electronic Devices: Insights From EuroTR. Journal: JACC. Cardiovascular interventions PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41137838 Summary: This real-world cohort study, derived from the EuroT.R. registry, evaluated procedural and clinical outcomes of tricuspid valve transcatheter edge-to-edge repair in 851 patients with cardiac implantable electronic device leads. The research, conducted across 26 centers, characterized the previously unclear long-term outcomes in this specific patient population. The study established the safety and effectiveness of tricuspid valve transcatheter edge-to-edge repair even with the presence of transvalvular device leads. These findings significantly broaden the applicability of this minimally invasive treatment for severe tricuspid regurgitation in patients with complex cardiac histories. Article 4: Transcatheter Tricuspid Valve Replacement and CLEFT After Tricuspid TEER. Journal: JACC. Cardiovascular interventions PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41137837 Summary: After Tricuspid T-TEER. This study described the techniques and outcomes for patients undergoing transcatheter tricuspid valve replacement after prior tricuspid transcatheter edge-to-edge repair. The research elucidated advanced electrosurgical techniques, such as C.L.E.F., that facilitate successful transcatheter tricuspid valve replacement in these complex cases. This paper establishes the feasibility and provides important procedural guidance for patients with severe tricuspid regurgitation who do not achieve optimal results from initial edge-to-edge repair. These findings represent a significant contribution to the evolving treatment landscape for advanced tricuspid valve disease. Article 5: Comparative Outcomes of Intracardiac vs Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion: Insights From EMERGE LAA Postapproval Study. Journal: JACC. Cardiovascular interventions PubMed Link: https://pubmed.ncbi.nlm.

Welcome to Cardiology Today – Recorded October 26, 2025. This episode summarizes 5 key cardiology studies on topics like Q. T. c. prolongation and interferon-gamma. Key takeaway: Machine Learning Predicts Q.T. Prolongation Better. Article Links: Article 1: Functional and Prognostic Implications of Different Iron Deficiency Definitions in Heart Failure: Insights From HEART-FID. (JACC. Heart failure) Article 2: Proinflammatory and cytotoxic CD38+HLA-DR+ effector memory CD8+ T cells are peripherally expanded in human cardiac allograft vasculopathy. (American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons) Article 3: Machine Learning-enabled Assessment of Risk for Drug-induced QT Prolongation at the Time of Prescribing. (Heart rhythm) Article 4: Indexed Aortic Valve Calcium Volume by Computed Tomography Angiography in Patients With Aortic Stenosis: Results of an International Multicenter Cohort Study. (JACC. Cardiovascular imaging) Article 5: Renal Function-Stratified Comparison of Complete vs Culprit-Only Revascularization in Older Patients With Myocardial Infarction and Multivessel Disease. (JACC. Cardiovascular interventions) Full episode page: https://podcast.explainheart.com/podcast/machine-learning-predicts-q-t-prolongation-better-10-26-25/ Featured Articles Article 1: Functional and Prognostic Implications of Different Iron Deficiency Definitions in Heart Failure: Insights From HEART-FID. Journal: JACC. Heart failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41137844 Summary: The HEART-FID trial, the largest study on iron repletion in heart failure, aimed to clarify how various definitions of iron deficiency impact functional capacity, hemoglobin levels, and patient outcomes. This research systematically evaluated different circulating iron indices as diagnostic criteria and explored their utility in defining treatment targets. The study’s findings provide crucial information for optimizing iron repletion strategies and establishing precise diagnostic thresholds for iron deficiency in heart failure patients. This advancement will guide clinicians in identifying and treating iron deficiency more effectively. Article 2: Proinflammatory and cytotoxic CD38+HLA-DR+ effector memory CD8+ T cells are peripherally expanded in human cardiac allograft vasculopathy. Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41138970 Summary: This study utilized high dimensional analysis of peripheral blood mononuclear cells to identify specific immune cell populations involved in human cardiac allograft vasculopathy. Researchers discovered a peripheral expansion of proinflammatory and cytotoxic C. D. 38 positive H. L. A. -D. R. positive effector memory C. D. 8 positive T cells in heart transplant patients with high-grade cardiac allograft vasculopathy. This finding directly implicates these distinct T cell subsets in the interferon-gamma axis pathogenesis of cardiac allograft vasculopathy. Identifying these specific immune cells provides potential new diagnostic biomarkers and therapeutic targets to improve outcomes in heart transplant recipients. Article 3: Machine Learning-enabled Assessment of Risk for Drug-induced QT Prolongation at the Time of Prescribing. Journal: Heart rhythm PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41139036 Summary: This research developed and evaluated machine learning approaches to predict drug-induced long Q. T. c. prolongation at the point of prescribing. Using 12-lead E. C. G. data and 5-fold cross-validation, the study trained X. G. Boost, deep neural network, and combined models. These machine learning-enabled methods demonstrated superior performance in predicting drug-induced Q. T. c. prolongation compared to established risk scores such as Tisdale and R. I. S. Q. -P. A. T. H. This advancement provides clinicians with a more accurate tool to assess Q. T. c. prolongation risk, potentially reducing adverse cardiac events. Article 4: Indexed Aortic Valve Calcium Volume by Computed Tomography Angiography in Patients With Aortic Stenosis: Results of an International Multicenter Cohort Study. Journal: JACC. Cardiovascular imaging PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41137846 Summary: This international multicenter cohort study investigated the utility of indexed aortic valve calcium volume from computed tomography angiography in patients with aortic stenosis. Researchers demonstrated that this quantitative measure provides robust diagnostic discrimination of disease severity when compared with echocardiography. Furthermore, the study established that computed tomography angiography-derived aortic valve calcium volume effectively informs risk stratification for patients with aortic stenosis. This finding offers a valuable and objective tool t

Welcome to Cardiology Today – Recorded October 25, 2025. This episode summarizes 5 key cardiology studies on topics like major adverse cardiovascular events and race-ethnicity. Key takeaway: 4A Classification for Tricuspid Regurgitation Risk. Article Links: Article 1: Maternal Socioeconomic Opportunity and Race-Ethnicity Intersect to Influence Fetal Brain Volumes in Congenital Heart Disease. (Journal of the American Heart Association) Article 2: The Obesity Paradox in Chronic Total Occlusion Percutaneous Coronary Intervention: Contemporary Outcomes Across Body Mass Index Categories. (The American journal of cardiology) Article 3: Changes in anticoagulation treatment and associated resolution or persistence of left atrial thrombus. Insights from LATTEE registry. (The American journal of cardiology) Article 4: Clinical and Technical Predictors of Adverse Cardiovascular Events Following Coronary Lithotripsy in the BENELUX-IVL Registry. (The American journal of cardiology) Article 5: The 4 a classification for prognostic stratification of patients with tricuspid regurgitation. A multicenter study. (International journal of cardiology) Full episode page: https://podcast.explainheart.com/podcast/4a-classification-for-tricuspid-regurgitation-risk-10-25-25/ Featured Articles Article 1: Maternal Socioeconomic Opportunity and Race-Ethnicity Intersect to Influence Fetal Brain Volumes in Congenital Heart Disease. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41128132 Summary: This multicenter study utilized magnetic resonance imaging to investigate the influence of maternal socioeconomic opportunity, using the Childhood Opportunity Index, and maternal race-ethnicity on fetal brain development in fetuses with and without complex congenital heart disease. The research aimed to establish how these social determinants of health contribute to neurodevelopmental outcome disparities, which are a persistent challenge in congenital heart disease. By assessing these factors, the study provides a foundational understanding to address the observed differences in neurocognitive outcomes. Article 2: The Obesity Paradox in Chronic Total Occlusion Percutaneous Coronary Intervention: Contemporary Outcomes Across Body Mass Index Categories. Journal: The American journal of cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41135790 Summary: This study examined the relationship between body mass index and outcomes following percutaneous coronary intervention for chronic total occlusion, addressing the known “obesity paradox” in other cardiac interventions where contemporary data for chronic total occlusion percutaneous coronary intervention is limited. Researchers analyzed 503 consecutive procedures in 453 patients from their institution between January 2018 and December 2023. The study aimed to clarify the impact of body mass index on both procedural success and long-term patient outcomes in this specific context. Article 3: Changes in anticoagulation treatment and associated resolution or persistence of left atrial thrombus. Insights from LATTEE registry. Journal: The American journal of cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41135789 Summary: Insights from L.A.T.T.E.E. registry. The L.A.T.T.E.E. registry investigated changes in anticoagulation treatment and their association with the resolution or persistence of left atrial thrombus in patients with atrial fibrillation or atrial flutter. This multicenter study included 3109 consecutive patients undergoing transoesophageal echocardiography before direct current cardioversion or ablation, identifying left atrial thrombus in 8.0 percent of these individuals. The research aimed to provide much-needed evidence on optimal anticoagulation strategies, addressing current guideline limitations for patients with left atrial thrombus. Article 4: Clinical and Technical Predictors of Adverse Cardiovascular Events Following Coronary Lithotripsy in the BENELUX-IVL Registry. Journal: The American journal of cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41135788 Summary: Registry. The B.E.N.E.L.U.X.-I.V.L. Registry conducted a retrospective analysis to identify clinical and procedural factors associated with major adverse cardiovascular events following intravascular lithotripsy for calcified coronary lesions. The study included 583 patients who underwent intravascular lithotripsy for 612 lesions between May 2019 and December 2024, employing Kaplan-Meier analysis and binary logistic regression. This research aimed to establish key predictors, thereby contributing to optimizing patient selection and improving outcomes for this treatment option. Article 5: The 4 a classification for prognostic stratification of patients with tricuspid regurgitation. A multicenter study. Journal: International journal of cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41135775 Summary: A multicenter study. This multicente

Welcome to Cardiology Today – Recorded October 25, 2025. This episode summarizes 5 key cardiology studies on topics like chest pain and heart disease. Key takeaway: Twin Pregnancy: Heart Disease Raises Heart Failure Risk. Article Links: Article 1: A Novel IgG- and IgM-Cleaving Endopeptidase, IceMG, for Antibody-Mediated Rejection. (American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons) Article 2: Erythropoietin prolongs graft survival in mice by counteracting trained immunity. (American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons) Article 3: Added value of cardiac magnetic resonance to clinical diagnostic criteria in the diagnosis of pericarditis: a retrospective cohort study. (Heart (British Cardiac Society)) Article 4: Twin pregnancies in women with heart disease are complicated by high risk of heart failure: data from the EORP ROPAC Registry. (Heart (British Cardiac Society)) Article 5: Cardioversion of atrial fibrillation and flutter: Trends, outcomes, and rhythm management strategies over two decades. (Heart rhythm) Full episode page: https://podcast.explainheart.com/podcast/twin-pregnancy-heart-disease-raises-heart-failure-risk-10-25-25/ Featured Articles Article 1: A Novel IgG- and IgM-Cleaving Endopeptidase, IceMG, for Antibody-Mediated Rejection. Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41135884 Summary: This study investigated IceMG, a novel recombinant endopeptidase designed to simultaneously cleave Immunoglobulin G and Immunoglobulin M, for its efficacy in antibody-mediated rejection. In rhesus macaques sensitized by sequential skin transplantations, a single intravenous dose of IceMG (2 milligrams per kilogram) significantly but transiently reduced total Immunoglobulin G and Immunoglobulin M levels. It also decreased allo- and xenoreactive Immunoglobulin G and Immunoglobulin M antibodies. These findings highlight IceMG’s potential as a therapeutic agent to temporarily clear harmful antibodies, offering a promising approach to improve outcomes in allo- and xenotransplantation by mitigating antibody-mediated rejection. Article 2: Erythropoietin prolongs graft survival in mice by counteracting trained immunity. Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41135883 Summary: This research explored erythropoietin’s immune-modulatory effects, specifically its impact on trained immunity and graft survival. C57BL/6 mice, receiving BALB/c cardiac allografts and treated with CpG (a trained immunity inducer), demonstrated accelerated rejection. However, treatment with erythropoietin, which binds to erythropoietin receptors on myeloid cells, effectively counteracted the epigenetic and metabolic reprogramming associated with trained immunity. This intervention resulted in a significant prolongation of cardiac allograft survival in the treated mice. The discovery suggests erythropoietin offers a novel therapeutic strategy to prevent transplant rejection by targeting trained immunity in macrophages, thereby improving long-term graft survival. Article 3: Added value of cardiac magnetic resonance to clinical diagnostic criteria in the diagnosis of pericarditis: a retrospective cohort study. Journal: Heart (British Cardiac Society) PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41136194 Summary: This retrospective cohort study evaluated the clinical utility of cardiac magnetic resonance in diagnosing pericarditis, particularly when traditional clinical criteria are transient or ambiguous. Consecutive patients referred for pericarditis evaluation by cardiac magnetic resonance between 2010 and 2024 at a tertiary hospital were screened. The study confirmed that while pericarditis is typically diagnosed clinically via symptoms like chest pain, pericardial rub, E.C.G. changes, and pericardial effusion, these findings can be transient. Cardiac magnetic resonance provides crucial added value by offering a more definitive diagnosis of pericardial inflammation or effusion. This enhances diagnostic accuracy and aids in guiding appropriate management for patients with challenging pericarditis presentations. Article 4: Twin pregnancies in women with heart disease are complicated by high risk of heart failure: data from the EORP ROPAC Registry. Journal: Heart (British Cardiac Society) PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41136193 Summary: This study, using data from the prospective global Registry Of Pregnancy And Cardiac disease (R.O.P.A.C.) from 2007-2018, tested the hypothesis that twin pregnancies in women with hea

Welcome to Cardiology Today – Recorded October 24, 2025. This episode summarizes 5 key cardiology studies on topics like genetic diagnosis and mineralocorticoid receptor antagonists. Key takeaway: Nonsteroidal MRAs Improve Heart Failure Outcomes.. Article Links: Article 1: P-Wave Indices and the Risks of Incident Atrial Fibrillation and Ischemic Stroke in Black Adults: The Jackson Heart Study. (Journal of the American Heart Association) Article 2: Clinically Actionable Hypertrophic Cardiomyopathy Genes in South Asian Indian Patients. (Journal of the American Heart Association) Article 3: Utility of High-Sensitivity Cardiac Troponin-T and N-Terminal Pro-B-Type Natriuretic Peptide to Predict Survival, Quality of Life, and Functional Status Changes After Transcatheter Aortic Valve Implantation. (Journal of the American Heart Association) Article 4: Nonsteroidal Versus Steroidal Mineralocorticoid Receptor Antagonists in Heart Failure: Real-World Evidence From a Multicenter Cohort Study. (Journal of the American Heart Association) Article 5: Rivaroxaban in Peripheral Artery Disease After Revascularization: Worst Events and Net Outcomes in VOYAGER PAD. (Journal of the American Heart Association) Full episode page: https://podcast.explainheart.com/podcast/nonsteroidal-mras-improve-heart-failure-outcomes-10-24-25/ Featured Articles Article 1: P-Wave Indices and the Risks of Incident Atrial Fibrillation and Ischemic Stroke in Black Adults: The Jackson Heart Study. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41133805 Summary: This prospective cohort study, involving 4900 Black adults without atrial fibrillation at baseline, investigated the relationship between electrocardiographic P-wave indices, as measures of atrial cardiomyopathy, and incident atrial fibrillation and ischemic stroke. The study found that specific P-wave indices were significantly associated with an increased risk of both developing atrial fibrillation and experiencing an ischemic stroke within this population. These findings highlight P-wave indices as valuable early prognostic markers, offering a new approach for risk stratification in Black adults who face a disproportionate burden of atrial fibrillation-related complications. This research establishes the clinical utility of these markers to guide targeted interventions and improve outcomes. Article 2: Clinically Actionable Hypertrophic Cardiomyopathy Genes in South Asian Indian Patients. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41128141 Summary: This study aimed to identify the prevalence of clinically actionable gene variants for primary hypertrophic cardiomyopathy in South Asian Indian patients, addressing existing data gaps and disparities in ancestry-specific variant interpretation. The research successfully identified distinct clinically actionable hypertrophic cardiomyopathy gene variants within this specific population, using established guidelines like the ClinGen Hereditary Cardiovascular Disorders Gene Curation Expert Panel. These findings provide crucial genetic insights, enhancing the understanding of hypertrophic cardiomyopathy’s etiology in South Asian Indian individuals. This work is essential for improving accurate genetic diagnosis, facilitating robust risk stratification, and enabling effective cascade screening within affected South Asian Indian families, ultimately minimizing interpretation disparities and improving patient care. Article 3: Utility of High-Sensitivity Cardiac Troponin-T and N-Terminal Pro-B-Type Natriuretic Peptide to Predict Survival, Quality of Life, and Functional Status Changes After Transcatheter Aortic Valve Implantation. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41128137 Summary: This prospective observational cohort study, involving 173 patients, evaluated the prognostic utility of pre-transcatheter aortic valve implantation N-terminal pro-B-type natriuretic peptide and high-sensitivity cardiac troponin T levels. The study discovered that elevated pre-procedural levels of both N-terminal pro-B-type natriuretic peptide and high-sensitivity cardiac troponin T were significant predictors of poorer survival, reduced quality of life, and diminished functional status changes after transcatheter aortic valve implantation. These findings demonstrate that these cardiac biomarkers offer substantial prognostic value beyond current clinical assessments. Consequently, these biomarkers can be incorporated into aortic valve guidelines to enhance risk stratification and guide more informed patient selection for transcatheter aortic valve implantation. Article 4: Nonsteroidal Versus Steroidal Mineralocorticoid Receptor Antagonists in Heart Failure: Real-World Evidence From a Multicenter Cohort Study. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/411281

Welcome to Cardiology Today – Recorded October 24, 2025. This episode summarizes 5 key cardiology studies on topics like N-terminal pro-B-type natriuretic peptide and myocardial infarction. Key takeaway: Exosomes Restore Injured Myocardium: Mechanisms. Article Links: Article 1: Association of Free Fatty Acids With Long-Term Adverse Outcomes in Patients With Premature Myocardial Infarction: A Prospective Cohort Study. (Journal of the American Heart Association) Article 2: Heart Failure With Preserved Ejection Fraction and Lower Natriuretic Peptide: Clinical Characteristics and Change in Natriuretic Peptide Levels. (Journal of the American Heart Association) Article 3: Molecular Mechanisms of Exosomes From Human iPSC-Cardiomyocytes and Mesenchymal Stem Cells in Restoring the Injured Myocardium. (Journal of the American Heart Association) Article 4: Seizures in Infants With Congenital Heart Disease: A National Cohort Study. (Journal of the American Heart Association) Article 5: Early-Life Sociodemographic Factors and Cardiovascular Health in Preadolescence Among Low-Income and Racially and Ethnically Diverse Children. (Journal of the American Heart Association) Full episode page: https://podcast.explainheart.com/podcast/exosomes-restore-injured-myocardium-mechanisms-10-24-25/ Featured Articles Article 1: Association of Free Fatty Acids With Long-Term Adverse Outcomes in Patients With Premature Myocardial Infarction: A Prospective Cohort Study. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41128147 Summary: This prospective cohort study investigated the association between free fatty acid (F.F.A.) levels and long-term major adverse cardiovascular events (M.A.C.E.) in 1168 patients with premature myocardial infarction. The research aimed to establish the independent prognostic value of free fatty acids and their combined effects with inflammatory markers, obesity, and insulin resistance on patient outcomes. By evaluating these factors, the study provides a foundation for understanding the role of metabolic markers in risk stratification after premature myocardial infarction. This information is crucial for identifying patients at higher risk and potentially informing future therapeutic strategies. Article 2: Heart Failure With Preserved Ejection Fraction and Lower Natriuretic Peptide: Clinical Characteristics and Change in Natriuretic Peptide Levels. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41128146 Summary: This study investigated the clinical characteristics and changes in N-terminal pro-B-type natriuretic peptide (N.T.-proB.N.P.) levels within heart failure with preserved ejection fraction (HeF.pEF) patients presenting with lower than expected natriuretic peptide levels. Using data from the S.U.P.P.O.R.T. (Supplemental Benefit of an Angiotensin Receptor Blocker in Hypertensive Patients With Stable Heart Failure Using Olmesartan) trial, the research aimed to characterize this specific subgroup. Understanding these characteristics is vital for recognizing patients with mild N.T.-proB.N.P. elevations, which is emphasized in recent heart failure guidelines. This provides crucial information for accurate diagnosis and tailored management strategies for a challenging heart failure phenotype. Article 3: Molecular Mechanisms of Exosomes From Human iPSC-Cardiomyocytes and Mesenchymal Stem Cells in Restoring the Injured Myocardium. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41128145 Summary: This study investigated the molecular mechanisms through which exosomes derived from human induced pluripotent stem cell-cardiomyocytes (i.P.S.C.-cardiomyocytes) and mesenchymal stem cells (M.S.C.s) contribute to restoring injured myocardium. Using a porcine ischemia-reperfusion injury model, the research identified shared and distinct effects of induced pluripotent stem cell-cardiomyocyte exosomes (i.C.M.-Exo) and mesenchymal stem cell exosomes (M.S.C.-Exo). The findings advance the understanding of how both types of exosomes improve cardiac function. This mechanistic insight is critical for developing more targeted and effective exosome-based regenerative therapies for myocardial repair. Article 4: Seizures in Infants With Congenital Heart Disease: A National Cohort Study. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41128144 Summary: This national cohort study analyzed the incidence, clinical characteristics, and outcomes of seizures in infants with congenital heart disease (C.H.D.). Utilizing the U.S. National Inpatient Sample Database from 2016 to 2020, the study compared demographics and clinical outcomes between congenital heart disease infants with and without seizures, after excluding specific confounding factors. The research established that infants with congenital heart disease have an increased risk of seizures. T

Welcome to Cardiology Today – Recorded October 24, 2025. This episode summarizes 5 key cardiology studies on topics like peri-operative complications and low-density lipoprotein cholesterol. Key takeaway: Minor Stroke: When to Use D.A.P.T. vs. Alteplase. Article Links: Article 1: Endothelial to mesenchymal transition in cardiovascular diseases: molecular insights and clinical perspectives. (European heart journal) Article 2: LDL-cholesterol in newborns and children with genetically verified familial hypercholesterolaemia: implications for cholesterol-based screening. (European heart journal) Article 3: Early outcomes of children with univentricular circulation undergoing Fontan surgery: the EuroFontan registry. (European heart journal) Article 4: Global Registries and Surveys Programme-Heart Failure (GRASP-HF): Rationale, study design and research implications. (European journal of heart failure) Article 5: Onset to Treatment Time and Early Neurological Deterioration of Dual Antiplatelet Therapy Versus Alteplase in Minor Stroke. (Journal of the American Heart Association) Full episode page: https://podcast.explainheart.com/podcast/minor-stroke-when-to-use-d-a-p-t-vs-alteplase-10-24-25/ Featured Articles Article 1: Endothelial to mesenchymal transition in cardiovascular diseases: molecular insights and clinical perspectives. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41128016 Summary: Endothelial to Mesenchymal Transition is a crucial process where endothelial cells transform into mesenchymal-like cells, contributing to structures like smooth muscle cells, osteoblasts, fibroblasts, or chondrocytes. This review establishes Endothelial to Mesenchymal Transition’s foundational role in embryonic heart development, particularly in forming cardiac valves from endocardial cushions. More recently, the process has been identified in various adult cardiovascular diseases, highlighting its significance beyond development. Elucidating the molecular mechanisms of Endothelial to Mesenchymal Transition offers potential therapeutic avenues for adult cardiovascular pathologies. Article 2: LDL-cholesterol in newborns and children with genetically verified familial hypercholesterolaemia: implications for cholesterol-based screening. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41127896 Summary: This study investigated the efficacy of cholesterol-based screening for Familial Hypercholesterolaemia in newborns and children using genetically verified cases from a Norwegian national cascade screening program. Researchers collected low-density lipoprotein cholesterol levels from umbilical cord blood in 113 newborns and venous blood in children with confirmed Familial Hypercholesterolaemia between 1998 and 2023. The findings assess the potential of cholesterol-based screening to efficiently identify Familial Hypercholesterolaemia in pediatric populations. This research directly supports the development of universal screening approaches for early detection and management of this genetic condition. Article 3: Early outcomes of children with univentricular circulation undergoing Fontan surgery: the EuroFontan registry. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41127893 Summary: The EuroFontan registry, a multicentre retrospective study across 21 European congenital heart disease and transplant centers, evaluated early outcomes and peri-operative complications in children undergoing Fontan completion for univentricular circulation. This comprehensive study highlights that while the Fontan operation has significantly advanced the management of functional single ventricle physiology, peri-operative complications remain a notable concern. The findings provide critical insights into the real-world challenges and outcomes following this complex cardiac surgery in a large international cohort. This data is invaluable for refining current surgical protocols and improving post-operative care strategies to enhance patient survival and quality of life. Article 4: Global Registries and Surveys Programme-Heart Failure (GRASP-HF): Rationale, study design and research implications. Journal: European journal of heart failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41126578 Summary: The Global Registries and Surveys Programme-Heart Failure (G.R.A.S.P.-H.F.) is a pan-European, snapshot, observational study designed to evaluate the real-world implementation of evidence-based Heart Failure therapies. This paper details the rationale and study design for G.R.A.S.P.-H.F., aiming to identify existing gaps between guideline recommendations and actual clinical practice. By assessing the uptake of advanced pharmacologic and device-based treatments, the program provides a critical framework for understanding barriers to optimal Heart Failure management. Ultimately, G.R.A.S.P.-H.F. will inform strategies to improve patient outcomes by ensuring more consi

Welcome to Cardiology Today – Recorded October 23, 2025. This episode summarizes 5 key cardiology studies on topics like lipid-lowering therapy and stroke risk. Key takeaway: Gestational Diabetes Harms Heart Function. Article Links: Article 1: Congenital heart disease in England: a national cohort study from fetal diagnosis to end of infancy. (Heart (British Cardiac Society)) Article 2: Use of a Generative Pretrained Transformer to Answer Questions and Facilitate a Large Randomized Controlled Trial. (Journal of the American Heart Association) Article 3: Effect of Statins in Patients With Hemodialysis-Dependent Chronic Kidney Disease: A Nationwide Cohort Study. (Journal of the American Heart Association) Article 4: Subclinical Cardiac Dysfunction in Women With Prior Gestational Diabetes: The Hispanic Community Study/Study of Latinos. (Journal of the American Heart Association) Article 5: Metabolic Syndrome and Risk of Moyamoya Vasculopathy and Subsequent Stroke in Young Adults. (Journal of the American Heart Association) Full episode page: https://podcast.explainheart.com/podcast/gestational-diabetes-harms-heart-function-10-23-25/ Featured Articles Article 1: Congenital heart disease in England: a national cohort study from fetal diagnosis to end of infancy. Journal: Heart (British Cardiac Society) PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41125330 Summary: This comprehensive national cohort study evaluated outcomes for all detected structural congenital heart disease cases in England, from fetal diagnosis through the first year of life. By linking national registries, researchers established an incident cohort to better quantify disease burden, including cases without cardiac intervention, which are often underestimated. This methodology provides a more accurate understanding of congenital heart disease prevalence and outcomes from birth to infancy, informing public health strategies and resource allocation. Article 2: Use of a Generative Pretrained Transformer to Answer Questions and Facilitate a Large Randomized Controlled Trial. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41120814 Summary: This study explored the utility of artificial intelligence in supporting clinical trials by developing a customized Generative Pretrained Transformer. Researchers implemented this customized G.P.T. within the Sleep S.M.A.R.T. (Sleep for Stroke Management and Recovery Trial) to provide real-time answers to procedure-related questions for clinical trial sites. The successful deployment of this A.I. tool demonstrates its potential to enhance efficiency and accelerate large-scale randomized controlled trials by rapidly addressing protocol and procedure queries. Article 3: Effect of Statins in Patients With Hemodialysis-Dependent Chronic Kidney Disease: A Nationwide Cohort Study. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41120813 Summary: This nationwide cohort study investigated the cardiovascular outcomes associated with statin use in patients initiating maintenance hemodialysis, stratified by their prior statin use. Utilizing a Korean health claims database, researchers employed multivariate Cox regression to assess these associations. The findings clarify the role of lipid-lowering therapy in hemodialysis-dependent chronic kidney disease, providing crucial evidence to inform guidelines that currently lack clear recommendations for this vulnerable patient population. Article 4: Subclinical Cardiac Dysfunction in Women With Prior Gestational Diabetes: The Hispanic Community Study/Study of Latinos. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41120812 Summary: This study examined the association between prior gestational diabetes and postpartum subclinical myocardial dysfunction in Hispanic women, a population with a high prevalence of gestational diabetes. Researchers leveraged the Hispanic Community Study/Study of Latinos cohort to assess early stages of myocardial dysfunction, a robust predictor of future heart failure, using imaging techniques. The findings underscore that gestational diabetes is associated with detectable subclinical cardiac abnormalities, highlighting the need for early cardiovascular risk stratification and preventative strategies in affected women. Article 5: Metabolic Syndrome and Risk of Moyamoya Vasculopathy and Subsequent Stroke in Young Adults. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41120811 Summary: This study aimed to determine if Metabolic Syndrome is associated with the development of Moyamoya vasculopathy and subsequent stroke risk in young adults. Using a nationwide Korean database of nearly 7 million adults aged 20 to 40 years, researchers retrospectively analyzed health screening data to identify newly diagnosed cases of Moyamoya vasculopathy and strokes. The findings esta

Welcome to Cardiology Today – Recorded October 23, 2025. This episode summarizes 5 key cardiology studies on topics like antibody-mediated rejection and adverse pregnancy outcomes. Key takeaway: Donor D.N.A. Detects Heart Transplant Rejection. Article Links: Article 1: Heart Stress and Blood Pressure Management in Older Adults: Post Hoc Analysis of the ASPREE Trial. (Circulation) Article 2: Efficacy and Safety of Omecamtiv Mecarbil in Heart Failure With Reduced Ejection Fraction According to Age: The GALACTIC-HF Trial. (JACC. Heart failure) Article 3: Donor-Derived Cell-Free DNA in Antibody-Mediated Rejection: An Analysis of the Surveillance HeartCare Outcomes Registry. (JACC. Heart failure) Article 4: Adverse Pregnancy Outcomes and Long-Term Risk of Atrial Fibrillation. (JAMA cardiology) Article 5: Short-Term Exposure to Low and High Temperatures and Mortality Among Patients With Heart Failure in Sweden. (JAMA cardiology) Full episode page: https://podcast.explainheart.com/podcast/donor-d-n-a-detects-heart-transplant-rejection-10-23-25/ Featured Articles Article 1: Heart Stress and Blood Pressure Management in Older Adults: Post Hoc Analysis of the ASPREE Trial. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41122849 Summary: This post hoc analysis of the A.S.P.R.E.E. (Aspirin in Reducing Events in the Elderly) trial investigated whether heart stress, indicated by age-adjusted elevated N-terminal pro-B-type natriuretic peptide levels, could improve cardiovascular disease risk stratification in older adults. The study included 11,941 community-dwelling participants to assess this biomarker’s utility in a complex patient population. Findings suggest that utilizing heart stress may enhance cardiovascular disease risk assessment, potentially supporting more individualized blood pressure management strategies for the elderly. This approach could lead to more tailored and effective therapeutic interventions by better identifying high-risk individuals. Article 2: Efficacy and Safety of Omecamtiv Mecarbil in Heart Failure With Reduced Ejection Fraction According to Age: The GALACTIC-HF Trial. Journal: JACC. Heart failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41123512 Summary: This analysis of the G.A.L.A.C.T.I.C.-H.F. (Global Approach to Lowering Adverse Cardiovascular Events Through Improving Contractility in Heart Failure) trial aimed to characterize the efficacy and safety of omecamtiv mecarbil across various age groups in patients with heart failure with reduced ejection fraction. Omecamtiv mecarbil is a selective cardiac myosin activator with minimal effects on blood pressure and heart rate, suggesting a favorable tolerability profile, especially in older individuals often burdened by comorbidities. The study evaluated how this drug’s clinical benefits and safety profile manifest across the age spectrum, addressing uncertainties regarding its use in an aging population. This research helps clarify the potential for individualized treatment strategies based on patient age in heart failure management. Article 3: Donor-Derived Cell-Free DNA in Antibody-Mediated Rejection: An Analysis of the Surveillance HeartCare Outcomes Registry. Journal: JACC. Heart failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41123513 Summary: This study, analyzing 2,240 heart transplant recipients from the S.H.O.R.E. (Surveillance HeartCare Outcomes Registry) registry, aimed to characterize the incidence and timing of biopsy-proven antibody-mediated rejection. A primary objective was to evaluate the performance characteristics of donor-derived cell-free D.N.A. as a biomarker for antibody-mediated rejection in a large, contemporary patient cohort. This research established important data on the utility of donor-derived cell-free D.N.A. in monitoring for rejection. Identifying reliable biomarkers like d.d.-c.f.D.N.A. is critical for improving early detection and management of rejection, thereby enhancing long-term outcomes for heart transplant patients. Article 4: Adverse Pregnancy Outcomes and Long-Term Risk of Atrial Fibrillation. Journal: JAMA cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41123920 Summary: This large population-based cohort study investigated the long-term risk of atrial fibrillation associated with six major adverse pregnancy outcomes. Employing a cosibling analysis to account for familial confounding, the research aimed to precisely determine these associations. The study established that women experiencing adverse pregnancy outcomes face increased long-term risks of developing atrial fibrillation. These findings are crucial for identifying high-risk women earlier in life, enabling targeted interventions to prevent atrial fibrillation and its serious complications. Article 5: Short-Term Exposure to Low and High Temperatures and Mortality Among Patients With Heart Failure in Sweden. Journal: JAMA cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41123904 Summar

Welcome to Cardiology Today – Recorded October 22, 2025. This episode summarizes 5 key cardiology studies on topics like aortic insufficiency and Korean National Health Insurance Service. Key takeaway: Off-Label Device Expands PDA Closure Options. Article Links: Article 1: Short-Term Effects of Personal-Level Environmental Temperature on Ambulatory Blood Pressure in Patients With Hypertension: A Multicity Panel Study. (Journal of the American Heart Association) Article 2: Occupational and Nonoccupational Physical Activity and Their Association With All-Cause, Cardiovascular, and Cancer Mortality in US Adults: A Prospective Cohort Study from the NHANES 2007 to 2018. (Journal of the American Heart Association) Article 3: Validation of the Hemodynamic Classification System for Hemodynamic-Related Events in Patients With Durable Left Ventricular Assist Devices. (Journal of the American Heart Association) Article 4: Antibiotic Exposure and Cardiovascular Disease Risk: A Nationwide Cohort Study. (Journal of the American Heart Association) Article 5: Off-Label Use of the Multifunctional Occluder for Transcatheter Patent Ductus Arteriosus Closure: An International Experience. (Journal of the American Heart Association) Full episode page: https://podcast.explainheart.com/podcast/off-label-device-expands-pda-closure-options-10-22-25/ Featured Articles Article 1: Short-Term Effects of Personal-Level Environmental Temperature on Ambulatory Blood Pressure in Patients With Hypertension: A Multicity Panel Study. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41120825 Summary: This multicity panel study aimed to clarify the short-term effects of personal-level environmental temperature on ambulatory blood pressure in 277 hypertensive patients across four Chinese cities. Researchers utilized continuous personal portable monitors to record both environmental temperature and ambulatory blood pressure. This robust methodology establishes a significant framework for understanding how individual thermal exposure impacts blood pressure management, which is crucial for optimizing cardiovascular health strategies in hypertensive populations. Article 2: Occupational and Nonoccupational Physical Activity and Their Association With All-Cause, Cardiovascular, and Cancer Mortality in US Adults: A Prospective Cohort Study from the NHANES 2007 to 2018. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41120824 Summary: 2007 to 2018. This prospective cohort study, utilizing data from the National Health and Nutrition Examination Survey (N.H.A.N.E.S.) between 2007 and 2018, sought to determine if achieving physical activity guidelines through occupational, nonoccupational, or combined activity differentially impacts all-cause, cardiovascular, and cancer mortality in U.S. adults. By meticulously observing participants aged 18 years or older and acquiring mortality data through the National Death Index, this research establishes a vital framework. This study is crucial for providing clarity on the specific health benefits associated with distinct types of physical activity, informing public health guidelines and personalized recommendations for improving longevity and reducing disease burden. Article 3: Validation of the Hemodynamic Classification System for Hemodynamic-Related Events in Patients With Durable Left Ventricular Assist Devices. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41120820 Summary: This study aimed to validate the new durable left ventricular assist device (d.L.V.A.D.) Hemodynamic Classification System designed for hemodynamic-related events, specifically right heart failure and aortic insufficiency. Researchers adjudicated, staged, and phenotyped these events at six months post-d.L.V.A.D. implantation, with the primary outcome being a composite of heart failure hospitalization or cardiac mortality. The validation of this classification system is critical for standardizing the assessment and management of common and serious complications in patients with durable left ventricular assist devices, which can significantly improve patient stratification and therapeutic guidance. Article 4: Antibiotic Exposure and Cardiovascular Disease Risk: A Nationwide Cohort Study. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41120818 Summary: This nationwide retrospective cohort study, utilizing data from the Korean National Health Insurance Service database, meticulously evaluated the potential association between long-term antibiotic exposure and cardiovascular disease (C.V.D.) risk in over two million individuals. The research aimed to provide essential epidemiological evidence to clarify this relationship, given that antibiotic use can alter gut microbiota, which is hypothesized to impact cardiovascular health. Establishing this association

Welcome to Cardiology Today – Recorded October 22, 2025. This episode summarizes 5 key cardiology studies on topics like screening algorithm and cardiac function. Key takeaway: AI Detects Cardiac Amyloidosis from Echo. Article Links: Article 1: Efficacy of aficamten in patients with obstructive hypertrophic cardiomyopathy and mild symptoms: results from the SEQUOIA-HCM trial. (European heart journal) Article 2: Cardiac amyloidosis detection from a single echocardiographic video clip: a novel artificial intelligence-based screening tool. (European heart journal) Article 3: Empagliflozin enhances metabolic efficiency and improves left ventricular hypertrophy in a hypertrophic cardiomyopathy mouse model. (European heart journal) Article 4: Role of NPPB for recovery post ventricular assist device in paediatric dilated cardiomyopathy: Single-cell multiomics. (ESC heart failure) Article 5: A U-shaped relationship between left ventricular ejection fraction and risk of worsening heart failure. (European journal of heart failure) Full episode page: https://podcast.explainheart.com/podcast/ai-detects-cardiac-amyloidosis-from-echo-10-22-25/ Featured Articles Article 1: Efficacy of aficamten in patients with obstructive hypertrophic cardiomyopathy and mild symptoms: results from the SEQUOIA-HCM trial. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41120118 Summary: The S.E.Q.U.O.I.A.-H.C.M. trial investigated the efficacy of aficamten in patients with obstructive hypertrophic cardiomyopathy and mild symptoms. This analysis, involving 118 patients with mild symptoms (New York Heart Association class I-II) from a larger cohort of 282, aimed to determine if benefits extended to this less symptomatic group. The study found that patients with obstructive hypertrophic cardiomyopathy and mild symptoms treated with aficamten experienced marked improvement in symptoms and functional capacity. This demonstrates aficamten’s consistent clinical benefits across a range of symptom severities, indicating its potential for earlier intervention in suitable patients. Article 2: Cardiac amyloidosis detection from a single echocardiographic video clip: a novel artificial intelligence-based screening tool. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40631729 Summary: This study assessed a novel artificial intelligence screening algorithm for detecting cardiac amyloidosis from a single echocardiographic video clip. Researchers trained a convolutional neural network using a multisite, multiethnic dataset of 2612 patients, with 52 percent having cardiac amyloidosis, utilizing transthoracic apical four-chamber video clips. The algorithm demonstrated accurate differentiation of cardiac amyloidosis from phenotypic mimics. This artificial intelligence tool offers a significant advance for rapid and less challenging screening of cardiac amyloidosis, potentially streamlining diagnosis and management. Article 3: Empagliflozin enhances metabolic efficiency and improves left ventricular hypertrophy in a hypertrophic cardiomyopathy mouse model. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40396194 Summary: This study investigated the therapeutic potential of empagliflozin, a sodium-glucose cotransporter 2 inhibitor, for hypertrophic cardiomyopathy. Researchers treated male mice harboring the myosin R403Q mutation, a hypertrophic cardiomyopathy model, with empagliflozin for sixteen weeks, evaluating changes through multi-nuclear M.R.I. and other analyses. The treatment demonstrated that empagliflozin enhanced metabolic efficiency and improved left ventricular hypertrophy in this mouse model. These preclinical findings suggest empagliflozin could offer a novel therapeutic strategy for key pathological features of hypertrophic cardiomyopathy, paving the way for future clinical trials. Article 4: Role of NPPB for recovery post ventricular assist device in paediatric dilated cardiomyopathy: Single-cell multiomics. Journal: ESC heart failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41116329 Summary: This study aimed to identify factors associated with L.V. functional recovery in children with idiopathic dilated cardiomyopathy after L.V. assist device implantation. Researchers used single-nucleus multiomics analysis on L.V. tissue collected at the time of L.V. assist device implantation. The study discovered specific factors, including the role of N.P.P.B., that are associated with improved L.V. function, enabling device explantation in a subset of patients. These findings establish a deeper understanding of recovery mechanisms and hold promise for developing personalized recovery strategies and patient selection for device explantation in pediatric dilated cardiomyopathy. Article 5: A U-shaped relationship between left ventricular ejection fraction and risk of worsening heart failure. Journal: European journal of heart failure PubMed Link: https://pubmed.

Welcome to Cardiology Today – Recorded October 21, 2025. This episode summarizes 5 key cardiology studies on topics like Graves’ disease and adolescents. Key takeaway: Metabolomics Guides BP Post-Bariatric Surgery. Article Links: Article 1: Ventricular arrhythmias during exercise in patients with mitral valve prolapse. (Heart (British Cardiac Society)) Article 2: Impact of Disease Duration on Left Atrial Function in Patients with Graves’ Disease. (Cardiology) Article 3: Plasma Metabolomic and Proteomic Signatures of Blood Pressure Management After Bariatric Surgery Among Adolescents. (Hypertension (Dallas, Tex. : 1979)) Article 4: Effect of Parity and Previous Preeclampsia on Maternal Hemodynamics. (Hypertension (Dallas, Tex. : 1979)) Article 5: Role of Ethnicity and Sex in Hypertension-Mediated Organ Damage in a Dual-Ethnic Cohort of Individuals With Hypertension. (Hypertension (Dallas, Tex. : 1979)) Full episode page: https://podcast.explainheart.com/podcast/metabolomics-guides-bp-post-bariatric-surgery-10-21-25/ Featured Articles Article 1: Ventricular arrhythmias during exercise in patients with mitral valve prolapse. Journal: Heart (British Cardiac Society) PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41115769 Summary: This multicenter study assessed the occurrence and severity of ventricular arrhythmias (V.A.) during exercise tests in 375 patients with mitral valve prolapse (M.V.P.). The research also explored the association between V.A. during exercise and the subsequent incidence of arrhythmic events during follow-up. This study establishes a clearer understanding of exercise-induced arrhythmias in M.V.P. patients, which is critical for their risk stratification and clinical management. Article 2: Impact of Disease Duration on Left Atrial Function in Patients with Graves’ Disease. Journal: Cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41115099 Summary: This cross-sectional study investigated the relationship between the duration of Graves’ disease and myocardial deformation parameters, specifically focusing on left atrial (L.A.) strain and left ventricular global longitudinal strain (L.V.-G.L.S.). Comprehensive echocardiographic assessment was performed on 90 patients with Graves’ disease, with disease duration categorized as short or long. The findings provide important insights into how the progression of Graves’ disease influences cardiac function, underscoring the potential for duration-dependent myocardial alterations. These results highlight the importance of timely intervention to preserve cardiac mechanics in patients with Graves’ disease. Article 3: Plasma Metabolomic and Proteomic Signatures of Blood Pressure Management After Bariatric Surgery Among Adolescents. Journal: Hypertension (Dallas, Tex. : 1979) PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41111440 Summary: This study utilized metabolomics and proteomics to identify preoperative plasma profiles that predict long-term elevated blood pressure changes after bariatric surgery in adolescents. Researchers analyzed 108 participants from the Teen-Longitudinal Assessment of Bariatric Surgery (Teen-L.A.B.S.) study, employing untargeted metabolomics via liquid chromatography-mass spectrometry and proteomics via tandem mass tag mass spectrometry. This research successfully identified specific molecular signatures that can better predict blood pressure outcomes compared to traditional risk factors. These findings advance personalized medicine by offering potential biomarkers for optimizing blood pressure management following bariatric surgery. Article 4: Effect of Parity and Previous Preeclampsia on Maternal Hemodynamics. Journal: Hypertension (Dallas, Tex. : 1979) PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41111413 Summary: This prospective longitudinal study examined the impact of parity and a history of preeclampsia on maternal hemodynamic profiles throughout pregnancy. Transthoracic echocardiography was used to assess hemodynamics at various gestational stages (12-15, 20-24, and 30-37 weeks) in groups of nulliparous women, parous women without previous preeclampsia, and parous women with previous preeclampsia. The study successfully delineates distinct longitudinal hemodynamic alterations linked to both parity and prior preeclampsia. This provides crucial information for understanding cardiovascular adaptations in pregnancy and for targeted monitoring in women at higher obstetric risk. Article 5: Role of Ethnicity and Sex in Hypertension-Mediated Organ Damage in a Dual-Ethnic Cohort of Individuals With Hypertension. Journal: Hypertension (Dallas, Tex. : 1979) PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41111403 Summary: This study investigated the combined influence of sex and ethnicity on vascular and renal hypertension-mediated organ damage (H.M.O.D.) in a dual-ethnic cohort of individuals with primary hypertension. Furthermore, the researchers explored the association of these dis

Welcome to Cardiology Today – Recorded October 21, 2025. This episode summarizes 5 key cardiology studies on topics like lipid peroxidation and recurrent pericarditis. Key takeaway: H.I.V. Donors Expand Heart Transplant Pool. Article Links: Article 1: ALDH2/eIF3E Interaction Modulates Protein Translation Critical for Cardiomyocyte Ferroptosis in Acute Myocardial Ischemia Injury. (Circulation) Article 2: Hypercontractility and Oxidative Stress Drive Creatine Kinase Dysfunction in Hypertrophic Cardiomyopathy. (Circulation) Article 3: Potential Pool of Cardiothoracic Organs from Donors with HIV. (The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation) Article 4: Outcomes of BK in Simultaneous Heart Kidney Transplant: A 3 Center Experience. (The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation) Article 5: Comparative analysis of recurrence rates following various cessation strategies for rilonacept in recurrent pericarditis. (Heart (British Cardiac Society)) Full episode page: https://podcast.explainheart.com/podcast/h-i-v-donors-expand-heart-transplant-pool-10-21-25/ Featured Articles Article 1: ALDH2/eIF3E Interaction Modulates Protein Translation Critical for Cardiomyocyte Ferroptosis in Acute Myocardial Ischemia Injury. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41111418 Summary: This study identified an interaction between acetaldehyde dehydrogenase 2 (ALDH2) and eukaryotic initiation factor 3 subunit E (eIF3E) that critically modulates protein translation in cardiomyocytes. This interaction plays a significant role in ferroptosis, an iron-dependent form of regulated cell death caused by lipid peroxidation, observed in acute myocardial ischemia injury. The research reveals how the Glu504Lys polymorphism of ALDH2, which affects a substantial portion of East Asians, influences this mechanism and contributes to increased risk. Understanding this molecular pathway provides a novel therapeutic target for preventing or mitigating acute myocardial infarction. Article 2: Hypercontractility and Oxidative Stress Drive Creatine Kinase Dysfunction in Hypertrophic Cardiomyopathy. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41111389 Summary: This study investigated the underlying mechanisms of myocardial energy depletion in hypertrophic cardiomyopathy (H.C.M.), a condition characterized by left ventricular hypertrophy and hypercontractility. The research discovered that hypercontractility and subsequent oxidative stress drive dysfunction of creatine kinase (C.K.), a key enzyme in cardiac energy homeostasis. This C.K. dysfunction exacerbates the energetic mismatch in H.C.M., where energy consumption surpasses production. These findings pinpoint specific targets for intervention, suggesting that strategies aimed at reducing hypercontractility, oxidative stress, or enhancing C.K. activity could improve cardiac energetics in H.C.M. patients. Article 3: Potential Pool of Cardiothoracic Organs from Donors with HIV. Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41115672 Summary: This study quantified the potential supply of cardiothoracic organs available from Human Immunodeficiency Virus (H.I.V.)-positive donors for H.I.V.-positive recipients, leveraging recent modifications to H.O.P.E. (Human Organ for Life) research guidelines. Using S.R.T.R. (Scientific Registry of Transplant Recipients) data, the researchers identified a substantial pool of H.I.V.-positive donors suitable for heart and lung transplantation. This research demonstrates the expanded eligibility criteria now allow cardiothoracic programs to participate in H.O.P.E. Act transplantation. These findings highlight a significant breakthrough in expanding access to life-saving organs for H.I.V.-positive individuals, potentially reducing transplant waitlist mortality. Article 4: Outcomes of BK in Simultaneous Heart Kidney Transplant: A 3 Center Experience. Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41115671 Summary: This retrospective multi-center study assessed the prevalence and outcomes of B.K. polyomavirus deoxyribonucleic acidemia (D.N.A.emia) and B.K. polyomavirus D.N.A.emia-associated nephropathy in simultaneous heart-kidney transplant recipients. Analyzing data from January 2005 to June 2022, the research provided crucial insights into the rates of B.K. polyomavirus infection in this specific patient population, where information has been limited. The findings help establish risk profiles and inform management strategies for B.K. polyomavirus infection, potentially improving long-term kidney and pati

Welcome to Cardiology Today – Recorded October 20, 2025. This episode summarizes 5 key cardiology studies on topics like long-term outcomes and atrial secondary tricuspid regurgitation. Key takeaway: Drug-Eluting Balloons for Pediatric Pulmonary Stenosis. Article Links: Article 1: Natural History of Atrial versus Ventricular Secondary Tricuspid Regurgitation: Insights from the Bronx-Valve Registry. (The American journal of cardiology) Article 2: Worsening Heart Failure Events in Adults with Mild-to-Moderate Chronic Kidney Disease. (American heart journal) Article 3: Neurological Development in Very Low Birth Weight Infants with Congenital Heart Disease at 3 Years of Age: A Japanese Multicenter Study. (Pediatric cardiology) Article 4: Drug-Eluting Balloons Versus Conventional Balloon Angioplasty for Peripheral Pulmonary Artery Stenosis in Childhood. (Pediatric cardiology) Article 5: Association Between G6PD Deficiency and Congenital Heart Disease Incidence and Hospital Outcomes. (Pediatric cardiology) Full episode page: https://podcast.explainheart.com/podcast/drug-eluting-balloons-for-pediatric-pulmonary-stenosis-10-20-25/ Featured Articles Article 1: Natural History of Atrial versus Ventricular Secondary Tricuspid Regurgitation: Insights from the Bronx-Valve Registry. Journal: The American journal of cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41110815 Summary: This study characterized the distinct features and long-term outcomes of severe atrial secondary tricuspid regurgitation (A-S.T.R.) and ventricular secondary tricuspid regurgitation (V-S.T.R.). Researchers identified adults with severe secondary tricuspid regurgitation within a quaternary-care health system and classified them based on left-sided cardiac conditions. By assessing these unique etiologies, the study helps delineate the natural history of tricuspid regurgitation, providing crucial information for understanding its progression. This distinction is vital for guiding future management and therapeutic strategies tailored to the specific pathophysiology of A-S.T.R. versus V-S.T.R. Article 2: Worsening Heart Failure Events in Adults with Mild-to-Moderate Chronic Kidney Disease. Journal: American heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41110741 Summary: This study aimed to quantify the burden of worsening heart failure (W.HeF.) events among adults with mild-to-moderate chronic kidney disease (C.K.D.). Researchers identified a contemporary cohort of adults with C.K.D., defined by specific estimated glomerular filtration rate (e.G.F.R.) and albuminuria criteria, within a large integrated healthcare system. The investigation documented outcomes including hospitalization for heart failure, which sheds light on the significant clinical impact of worsening heart failure in this vulnerable patient population. Understanding this burden underscores the need for proactive management strategies to mitigate adverse cardiovascular events in individuals with co-existing mild-to-moderate C.K.D. Article 3: Neurological Development in Very Low Birth Weight Infants with Congenital Heart Disease at 3 Years of Age: A Japanese Multicenter Study. Journal: Pediatric cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41109872 Summary: This multicenter cohort study investigated neurodevelopmental outcomes and identified risk factors for impairment in very low birth weight (V.L.B.W.) infants with congenital heart disease (C.H.D.). Researchers assessed neurodevelopment at three years of age in V.L.B.W. infants born without known genetic anomalies. The study successfully established the prevalence of neurodevelopmental impairment and elucidated associated risk factors within this highly vulnerable population. These findings are crucial for developing targeted early intervention programs and improving long-term neurological outcomes for V.L.B.W. infants with C.H.D. Article 4: Drug-Eluting Balloons Versus Conventional Balloon Angioplasty for Peripheral Pulmonary Artery Stenosis in Childhood. Journal: Pediatric cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41109871 Summary: This study evaluated the efficacy of drug-eluting balloon angioplasty (D.E.B.A.) compared to conventional balloon angioplasty (C.B.A.) for treating peripheral pulmonary artery stenoses (P.A.S.) in children. A retrospective qualitative analysis was performed on individual stenoses in pediatric patients. The research aimed to determine if drug-eluting balloons offer a superior or comparable therapeutic option for this common congenital heart defect complication. This comparison provides important clinical data to guide interventional cardiologists in selecting optimal treatment strategies for pediatric P.A.S. Article 5: Association Between G6PD Deficiency and Congenital Heart Disease Incidence and Hospital Outcomes. Journal: Pediatric cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41109870 Summary: This study explored a potential association between G6

Welcome to Cardiology Today – Recorded October 20, 2025. This episode summarizes 5 key cardiology studies on topics like Defibrillation lead and echocardiography. Key takeaway: New Defib Lead for LBB Pacing. Article Links: Article 1: The Predictive Power of Left Atrial Reservoir Strain for Long-Term Atrial Fibrillation in The Atherosclerosis Risk in Communities (ARIC) Study. (Heart rhythm) Article 2: Safety and performance of a novel defibrillation lead for left bundle branch area placement: primary results of the LEADR LBBAP clinical trial. (Heart rhythm) Article 3: Optimization of Pacing for Patients Receiving Ineffective Cardiac Resynchronization Therapy. (Heart rhythm) Article 4: Clinical and Prognostic Implications of Precipitating Factors in Patients with Spontaneous Coronary Artery Dissection. (The American journal of cardiology) Article 5: Incidence and Predictors of Atrial Fibrillation After Cavotricuspid Isthmus Ablation for Typical Atrial Flutter. (The American journal of cardiology) Full episode page: https://podcast.explainheart.com/podcast/new-defib-lead-for-lbb-pacing-10-20-25/ Featured Articles Article 1: The Predictive Power of Left Atrial Reservoir Strain for Long-Term Atrial Fibrillation in The Atherosclerosis Risk in Communities (ARIC) Study. Journal: Heart rhythm PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41110530 Summary: This study aimed to assess the standalone predictive power of Left Atrial Reservoir Strain (L.A.R.S.) measures obtained from two-dimensional echocardiograms for long-term Atrial Fibrillation (A.fib) prediction over 5 and 10 years. Researchers analyzed data from 5,442 older adults (median age 74) from the Atherosclerosis Risk in Communities (A.R.I.C.) study who had no prior Atrial Fibrillation. By investigating L.A.R.S., the study sought to determine if this measure could independently predict future Atrial Fibrillation development. Establishing such a predictive value would enable earlier identification of individuals at high risk for Atrial Fibrillation, facilitating timely monitoring and intervention strategies. Article 2: Safety and performance of a novel defibrillation lead for left bundle branch area placement: primary results of the LEADR LBBAP clinical trial. Journal: Heart rhythm PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41110529 Summary: The L.E.A.D.R. L.B.B.A.P. clinical trial investigated the defibrillation efficacy at implant and the safety profile of the OmniaSecure lead when used for Left Bundle Branch Area Pacing (L.B.B.A.P.). This study aimed to determine if this lead, previously successful in Right Ventricular placement, could serve as a viable option for physiological pacing in patients requiring an implantable cardioverter-defibrillator (I.C.D.). By enrolling patients indicated for I.C.D. placement globally, the trial sought to establish the lead’s performance. Successful integration of Left Bundle Branch Area Pacing with defibrillation capabilities could offer a significant advancement in cardiac rhythm management for these patients. Article 3: Optimization of Pacing for Patients Receiving Ineffective Cardiac Resynchronization Therapy. Journal: Heart rhythm PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41110528 Summary: This study investigated the characteristics and efficacy of pacing optimization strategies for patients experiencing a high percentage of ineffective Cardiac Resynchronization Therapy (C.R.T.). High ineffective C.R.T. pacing ( percenti-C.R.T.) has been linked to poor patient prognosis, yet optimal follow-up settings for these individuals remain unclear. Researchers assessed 225 consecutive patients between 2018 and 2024 using the EffectivC.R.T. system from Medtronic Inc. The goal was to establish effective methods for optimizing C.R.T. delivery, potentially improving outcomes for patients who are not adequately responding to standard therapy. Article 4: Clinical and Prognostic Implications of Precipitating Factors in Patients with Spontaneous Coronary Artery Dissection. Journal: The American journal of cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41110817 Summary: This study aimed to evaluate the clinical and prognostic relevance of precipitating factors in patients presenting with Spontaneous Coronary Artery Dissection (S.C.A.D.), a rare cause of acute coronary syndrome (A.C.S.). While S.C.A.D. has traditionally been linked to pregnancy, it is increasingly associated with emotional and physical stressors. The prospective Spanish S.C.A.D. Registry (R.N.-D.C.E.) provided data from 388 patients across 34 centers since 2015, with coronary angiograms reviewed. By clarifying the impact of these factors, the research contributes to better understanding S.C.A.D. etiology and improving risk stratification and patient management. Article 5: Incidence and Predictors of Atrial Fibrillation After Cavotricuspid Isthmus Ablation for Typical Atrial Flutter. Journal: The American journal of cardiology PubMed Link: https://pubme

Welcome to Cardiology Today – Recorded October 19, 2025. This episode summarizes 5 key cardiology studies on topics like sarcomere and intensive care unit. Key takeaway: Targeting MTSS1 Improves DCM Contractility. Article Links: Article 1: Vitamin B6 (pyridoxal 5′ phosphate) antagonizes carotid body P2X3 receptors in hypertension. (Cardiovascular research) Article 2: Peptide Deformylase Regulates Aldosterone Production Through Calbindin 1. (Hypertension (Dallas, Tex. : 1979)) Article 3: Reduced Expression of MTSS1 Increases Sarcomere Number and Improves Contractility in Select Forms of Monogenic DCM. (JACC. Basic to translational science) Article 4: Fostering Psychological Safety and Resilience in the ICU: Implementing Structured Peer Support. (European heart journal. Acute cardiovascular care) Article 5: Targeting the Association between Inter-Arm Blood Pressure Difference and Subclinical Organ Damage: Findings from the Pamela Study. (American journal of hypertension) Full episode page: https://podcast.explainheart.com/podcast/targeting-mtss1-improves-dcm-contractility-10-19-25/ Featured Articles Article 1: Vitamin B6 (pyridoxal 5′ phosphate) antagonizes carotid body P2X3 receptors in hypertension. Journal: Cardiovascular research PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41094718 Summary: This study investigated if pyridoxal 5′ phosphate (P.L.P.), the active form of vitamin B6, could treat hypertension by antagonizing P2X3 receptors in carotid bodies. Using a multipronged approach, researchers found that P.L.P. inhibited P2X3 receptor activity in Spontaneously Hypertensive rats (S.H.R.). This antagonism can attenuate carotid body hyperexcitability, which underlies chemoreflex-mediated sympathetic overactivity in hypertension. These findings suggest P.L.P. is a potential therapeutic agent for hypertension by specifically targeting carotid body P2X3 receptors. Article 2: Peptide Deformylase Regulates Aldosterone Production Through Calbindin 1. Journal: Hypertension (Dallas, Tex. : 1979) PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41104452 Summary: This research aimed to clarify the role of peptide deformylase in aldosterone overproduction, particularly in aldosterone-producing adenoma. Investigators validated that peptide deformylase expression was significantly upregulated in enlarged aldosterone-producing adenomas. The study discovered that peptide deformylase regulates aldosterone production through calbindin 1, revealing a novel molecular mechanism. This finding advances the understanding of primary aldosteronism pathophysiology and identifies peptide deformylase as a potential new therapeutic target for aldosterone overproduction. Article 3: Reduced Expression of MTSS1 Increases Sarcomere Number and Improves Contractility in Select Forms of Monogenic DCM. Journal: JACC. Basic to translational science PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41108838 Summary: This study explored the impact of M.T.S.S.1 protein expression on heart failure and contractility in dilated cardiomyopathy (D.C.M.). Human genetic analyses revealed that a variant lowering cardiac M.T.S.S.1 expression was linked to significantly improved survival in individuals with T.T.N. dilated cardiomyopathy. Experimental knockdown of M.T.S.S.1 via small interfering R.N.A. (s.i.R.N.A.) in induced pluripotent stem cell-derived cardiomyocytes improved sarcomere number and contractility in models of T.T.N., C.S.R.P.3, and R.B.M.20 related D.C.M. These results indicate that targeting M.T.S.S.1 expression offers a promising therapeutic strategy to enhance cardiac function and survival in specific monogenic forms of dilated cardiomyopathy. Article 4: Fostering Psychological Safety and Resilience in the ICU: Implementing Structured Peer Support. Journal: European heart journal. Acute cardiovascular care PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41094715 Summary: This review outlines foundational pillars for establishing structured peer support programs to enhance psychological safety and resilience among intensive care unit (I.C.U.) professionals. The review establishes that these programs, delivered by trained colleagues, offer a low-threshold and scalable intervention for addressing psychological distress, moral injury, and burnout in the I.C.U. environment. It details five key components crucial for successful program implementation. Such interventions are vital for improving individual well-being, fostering better team dynamics, and ultimately enhancing patient safety within the intensive care unit. Article 5: Targeting the Association between Inter-Arm Blood Pressure Difference and Subclinical Organ Damage: Findings from the Pamela Study. Journal: American journal of hypertension PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41099834 Summary: This research investigated the connection between inter-arm blood pressure (B.P.) difference and subclinical cardiac and vascular damage within a community-based population. The

Welcome to Cardiology Today – Recorded October 19, 2025. This episode summarizes 5 key cardiology studies on topics like cardiogenic shock and drug-eluting stents. Key takeaway: R.B.M.20 Therapy Reverses HeF.pEF Diastolic Dysfunction. Article Links: Article 1: Clinical Outcomes Following Percutaneous Coronary Intervention with Drug-Eluting Stents and Drug-Coated Balloons in Lesion with Eruptive Calcified Nodules. (The American journal of cardiology) Article 2: Deep Dive Rendezvous as a Novel Alternative Technique for Conventional Externalization in Retrograde Chronic Total Occlusion Interventions. (The American journal of cardiology) Article 3: Comparison of dual- versus triple-targeted drug therapy for patients with left-to-right shunt congenital heart disease-associated pulmonary arterial hypertension. (Cardiology) Article 4: Cardiogenic Shock in Takotsubo vs. Acute Myocardial Infarction: Insights from The National Readmission Database 2016-2022. (The Canadian journal of cardiology) Article 5: Rbm20 antisense oligonucleotides alleviate diastolic dysfunction in a mouse model of cardiometabolic heart failure (HFpEF). (Cardiovascular research) Full episode page: https://podcast.explainheart.com/podcast/r-b-m-20-therapy-reverses-hef-pef-diastolic-dysfunction-10-19-25/ Featured Articles Article 1: Clinical Outcomes Following Percutaneous Coronary Intervention with Drug-Eluting Stents and Drug-Coated Balloons in Lesion with Eruptive Calcified Nodules. Journal: The American journal of cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41109611 Summary: This study investigated clinical outcomes of percutaneous coronary intervention for high-risk eruptive calcified nodules using either drug-eluting stents or drug-coated balloons. Researchers conducted optical coherence tomography-guided P.C.I. in 1,975 patients to gather comparative data on these treatment strategies, which was previously unavailable. This research provides a crucial foundation for understanding the optimal P.C.I. approach for these complex lesions. The findings will help improve patient care by guiding device selection for eruptive calcified nodules. Article 2: Deep Dive Rendezvous as a Novel Alternative Technique for Conventional Externalization in Retrograde Chronic Total Occlusion Interventions. Journal: The American journal of cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41109610 Summary: This article introduces and examines the “Deep Dive Rendezvous” technique as an alternative to conventional externalization in retrograde chronic total occlusion percutaneous coronary intervention. The research addresses significant challenges of conventional externalization, such as procedural complexity, increased equipment requirements, and risk of fragile collateral vessel rupture. This innovative technique offers a simpler and potentially safer approach for complex C.T.O.-P.C.I. when antegrade methods are insufficient. The study establishes a valuable new tool for interventional cardiologists, aiming to enhance procedural safety and improve patient outcomes. Article 3: Comparison of dual- versus triple-targeted drug therapy for patients with left-to-right shunt congenital heart disease-associated pulmonary arterial hypertension. Journal: Cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41105551 Summary: This study compared the efficacy of triple- versus dual-targeted drug therapy in 67 patients with left-to-right shunt congenital heart disease-associated pulmonary arterial hypertension. The research also evaluated treatment outcomes and prognosis in this cohort, further categorizing patients based on potential defect closure. Given the limited evidence on optimal targeted therapy for this complex condition, the study provides crucial data. This investigation advances the understanding of effective management strategies, aiming to improve the long-term prognosis for individuals with congenital heart disease-associated pulmonary arterial hypertension. Article 4: Cardiogenic Shock in Takotsubo vs. Acute Myocardial Infarction: Insights from The National Readmission Database 2016-2022. Journal: The Canadian journal of cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41109669 Summary: Acute Myocardial Infarction: Insights from The National Readmission Database 2016-2022. This study used the Nationwide Readmissions Database from 2016 to 2022 to compare cardiogenic shock in Takotsubo cardiomyopathy versus acute myocardial infarction. Researchers identified hospitalizations for cardiogenic shock, classifying cases as either T.C.-C.S. or A.M.I.-C.S., to analyze demographic features, clinical characteristics, and treatment strategies. This investigation provides critical comparative data on these distinct causes of cardiogenic shock, an area previously understudied for Takotsubo cardiomyopathy. The findings are vital for accurate diagnosis, tailored management, and improving patient outcomes in both severe conditions. Arti

Welcome to Cardiology Today – Recorded October 18, 2025. This episode summarizes 5 key cardiology studies on topics like no-reflow phenomenon and Left Atrial Appendage. Key takeaway: T.A.V.I. Valve Durability: 6-Year Data Guides Choice. Article Links: Article 1: Interplay of Race and Community Characteristics on Health Disparities Among Medicare Beneficiaries With Peripheral Artery Disease. (The American journal of cardiology) Article 2: Early Aortic Valve Replacement Versus Clinical Surveillance in Asymptomatic Patients With Severe Aortic Stenosis. (The American journal of cardiology) Article 3: 6 Year Follow-Up of Balloon-Expandable Versus Self-Expanding Transcatheter Aortic Valves: A Propensity-Matched Analysis. (The American journal of cardiology) Article 4: Remodeling and Reverse-Remodeling of Left Atrium and Appendage After Catheter Ablation for Atrial Fibrillation. (The American journal of cardiology) Article 5: Angiographic No-Reflow in Patients With Acute Coronary Syndrome Caused by Calcified Nodules. (The American journal of cardiology) Full episode page: https://podcast.explainheart.com/podcast/t-a-v-i-valve-durability-6-year-data-guides-choice-10-18-25/ Featured Articles Article 1: Interplay of Race and Community Characteristics on Health Disparities Among Medicare Beneficiaries With Peripheral Artery Disease. Journal: The American journal of cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40784469 Summary: This retrospective cohort study utilized 100 percent Medicare Standard Analytic Files from 2017 to 2023 to investigate the combined effects of race and community characteristics on outcomes and treatment utilization among Medicare beneficiaries with Peripheral Artery Disease. It aimed to move beyond individual factor analysis to understand the complex interactions influencing health disparities in this patient population. By examining both race and community factors together, the study establishes a comprehensive framework for identifying specific drivers of unequal Peripheral Artery Disease care. This foundational research is critical for developing more targeted and effective interventions to reduce health disparities. Article 2: Early Aortic Valve Replacement Versus Clinical Surveillance in Asymptomatic Patients With Severe Aortic Stenosis. Journal: The American journal of cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40490131 Summary: This study aimed to compare the clinical outcomes of early Aortic Valve Replacement versus clinical surveillance in asymptomatic patients with high-gradient severe Aortic Stenosis. Researchers identified 596 such patients from the CURRENT A.S. Registry-2, allocating 285 to an initial Aortic Valve Replacement strategy and 311 to clinical surveillance. By directly comparing these two distinct management approaches, the study establishes a crucial evaluation of optimal timing for intervention. The findings will provide essential evidence to inform clinical decision-making regarding Aortic Valve Replacement for this challenging patient population. Article 3: 6 Year Follow-Up of Balloon-Expandable Versus Self-Expanding Transcatheter Aortic Valves: A Propensity-Matched Analysis. Journal: The American journal of cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40490129 Summary: This study compared in-hospital, 1-year, and 6-year outcomes of balloon-expandable versus self-expanding Transcatheter Aortic Valve Implantation performed via transfemoral access. Researchers analyzed a large single-center cohort, creating propensity-score matched groups of 683 patients with balloon-expandable valves and 680 patients with self-expanding valves. This robust methodology establishes a crucial long-term comparison between contemporary Transcatheter Aortic Valve Implantation devices. The findings from this extensive follow-up will provide essential evidence to inform valve selection and optimize patient management following Transcatheter Aortic Valve Implantation. Article 4: Remodeling and Reverse-Remodeling of Left Atrium and Appendage After Catheter Ablation for Atrial Fibrillation. Journal: The American journal of cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40484266 Summary: This study evaluated remodeling and reverse-remodeling of the Left Atrium and Left Atrial Appendage following catheter ablation for Atrial Fibrillation. Researchers enrolled 372 patients who underwent ablation and had both pre- and post-procedure contrast computed tomography images. From these images, specific metrics including Left Atrial volume, Left Atrial Emptying Fraction, Left Atrial Appendage volume, and Left Atrial Appendage Emptying Fraction were precisely measured. This research establishes a detailed method to objectively track and quantify structural and functional changes in the Left Atrium and Left Atrial Appendage, offering valuable insights into the mechanisms of successful Atrial Fibrillation ablation. Article 5: Angiographic No-Reflow in Patients With

Welcome to Cardiology Today – Recorded October 18, 2025. This episode summarizes 5 key cardiology studies on topics like heart failure hospitalization and modifiable risk factors. Key takeaway: Causal Factors for Bradyarrhythmia Revealed. Article Links: Article 1: Outcomes of moderate mixed aortic valve stenosis and regurgitation. (European heart journal) Article 2: Urinary tract infection and continuation of sodium-glucose cotransporter-2 inhibitors in diabetic patients. (European heart journal) Article 3: Angina after percutaneous coronary interventions. (European heart journal) Article 4: Prospective multicentre single-arm study of an interatrial shunt in heart failure with reduced ejection fraction (SUSTAIN-HF): 1-year clinical and haemodynamic outcomes. (Heart (British Cardiac Society)) Article 5: Association between Modifiable Risk Factors and Bradyarrhythmia: A Mendelian Randomization Study. (Heart rhythm) Full episode page: https://podcast.explainheart.com/podcast/causal-factors-for-bradyarrhythmia-revealed-10-18-25/ Featured Articles Article 1: Outcomes of moderate mixed aortic valve stenosis and regurgitation. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41104570 Summary: This study investigates mortality outcomes in patients with moderate mixed aortic valve disease (M.A.V.D.), characterized by both moderate aortic stenosis (A.S.) and moderate aortic regurgitation (A.R.). The research compares survival rates of these patients against those with isolated severe A.S. or severe A.R. Furthermore, it evaluates the impact of symptoms or a left ventricular ejection fraction (L.V.E.F.) below 50 percent on patient prognosis in M.A.V.D. These findings provide critical data to inform clinical guidelines, which currently lack specific recommendations for aortic valve replacement (A.V.R.) in this particular population. Article 2: Urinary tract infection and continuation of sodium-glucose cotransporter-2 inhibitors in diabetic patients. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41104542 Summary: This territory-wide cohort study assessed the clinical impact of incident urinary tract infection (U.T.I.) and subsequent discontinuation of sodium-glucose cotransporter-2 (S.G.L.T.2) inhibitors in patients with type 2 diabetes mellitus. It specifically examined primary cardiovascular composite outcomes, including heart failure hospitalization, stroke, and myocardial infarction. The research offers crucial insights into the real-world management of S.G.L.T.2 inhibitor therapy following U.T.I. and its implications for long-term cardiovascular protection. The findings underscore the importance of carefully considering S.G.L.T.2 inhibitor continuation post-U.T.I. to optimize patient benefits. Article 3: Angina after percutaneous coronary interventions. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41104537 Summary: This review addresses the persistent or recurrent angina that can occur after percutaneous coronary intervention (P.C.I.) for stable coronary artery disease, a common and often underexplored clinical issue. It highlights the significant gap in current clinical practice guidelines regarding the causative diagnosis, effective prevention, and optimal management strategies for this condition. The article aims to enhance understanding of this problem, which frequently undermines the primary goal of P.C.I. to alleviate anginal symptoms. This work establishes a clear need for improved diagnostic and therapeutic pathways to address post-P.C.I. angina and enhance patient quality of life. Article 4: Prospective multicentre single-arm study of an interatrial shunt in heart failure with reduced ejection fraction (SUSTAIN-HF): 1-year clinical and haemodynamic outcomes. Journal: Heart (British Cardiac Society) PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41107031 Summary: The S.U.S.T.A.I.N.-H.F. study, a prospective, multicenter, single-arm cohort, evaluated the 1-year clinical and hemodynamic outcomes of an interatrial shunt device in 120 symptomatic heart failure with reduced ejection fraction (HeF.rE.F.) patients. Participants, all with a left ventricular ejection fraction (L.V.E.F.) of 40 percent or less and on guideline-directed medical therapy, received the device. This study establishes crucial evidence for the safety and efficacy profile of this interventional strategy for HeF.rE.F., demonstrating its potential as a novel therapeutic option. The findings provide valuable data supporting further investigation and potential clinical application of interatrial shunts to improve patient outcomes. Article 5: Association between Modifiable Risk Factors and Bradyarrhythmia: A Mendelian Randomization Study. Journal: Heart rhythm PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41106528 Summary: This Mendelian randomization study investigated the causal associations between several modifiable risk factors and bradyarrhythmia, with the

Welcome to Cardiology Today – Recorded October 17, 2025. This episode summarizes 5 key cardiology studies on topics like recoarctation and device closure. Key takeaway: B.P. Variability Detects Alpha-Synucleinopathy. Article Links: Article 1: Risk Factors for Reintervention Following Treatment for Aortic Coarctation With or Without Aortic Arch Hypoplasia in Sweden: From Isolated Coarctation to Complex Bi- and Univentricular Congenital Heart Disease. (Journal of the American Heart Association) Article 2: Automated Office Blood Pressure Measurements in Waiting Room or Isolated Room for Diagnosis and Phenotyping of Hypertension. (Journal of the American Heart Association) Article 3: Blood Pressure Variability as a Diagnostic Marker for α-Synucleinopathy in Patients With Orthostasis. (Journal of the American Heart Association) Article 4: Outcomes Analysis of Transcatheter Closure of Atrial Septal Defects. (Journal of the American Heart Association) Article 5: Social Determinants of Health Correlates and Atherosclerotic Cardiovascular Disease Risk Among Adults in Baltimore: The EngAGE With Heart Study. (Journal of the American Heart Association) Full episode page: https://podcast.explainheart.com/podcast/b-p-variability-detects-alpha-synucleinopathy-10-17-25/ Featured Articles Article 1: Risk Factors for Reintervention Following Treatment for Aortic Coarctation With or Without Aortic Arch Hypoplasia in Sweden: From Isolated Coarctation to Complex Bi- and Univentricular Congenital Heart Disease. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41085210 Summary: This study aimed to identify the prevalence and risk factors for requiring reintervention for recoarctation of the aorta in patients who underwent treatment for coarctation of the aorta. The investigation included individuals with isolated coarctation as well as those with complex bi- and univentricular congenital heart disease, drawing data from the S.W.E.D.C.O.N. registry. Understanding these risk factors is crucial for predicting which patients are at higher risk for long-term complications like recoarctation of the aorta or arterial hypertension, enabling more personalized long-term surveillance. This research provides valuable information to improve the long-term management and outcomes for patients post-coarctation of the aorta repair. Article 2: Automated Office Blood Pressure Measurements in Waiting Room or Isolated Room for Diagnosis and Phenotyping of Hypertension. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41085208 Summary: This cross-sectional study evaluated the diagnostic performance of automated office blood pressure measurement in different settings for hypertension. Researchers compared standard office blood pressure, unattended automated office blood pressure measurement in an isolated room, and automated office blood pressure measurement in a waiting room against daytime ambulatory blood pressure measurement as the reference standard. The findings suggest that automated office blood pressure measurement performed in a waiting room could enhance the efficiency of hypertension diagnosis without requiring a dedicated isolated room. This offers a practical and scalable approach to improve hypertension screening and phenotyping in busy clinical environments. Article 3: Blood Pressure Variability as a Diagnostic Marker for α-Synucleinopathy in Patients With Orthostasis. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41085193 Summary: This prospective study aimed to investigate the diagnostic utility of ambulatory blood pressure monitoring in identifying alpha-synucleinopathy among patients experiencing orthostasis. Building on the established understanding that individuals with alpha-synucleinopathy exhibit significant blood pressure variability, the researchers recruited consecutive patients with orthostatic dizziness for detailed examination, including ambulatory blood pressure monitoring. The study’s objective was to determine if blood pressure variability, as measured by ambulatory monitoring, can serve as a reliable diagnostic marker for this neurodegenerative condition. Establishing such a marker could lead to earlier and more precise diagnosis of alpha-synucleinopathy, improving patient management and potentially guiding targeted therapies. Article 4: Outcomes Analysis of Transcatheter Closure of Atrial Septal Defects. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41085192 Summary: This single-center retrospective study spanning from 2006 to 2021 analyzed the outcomes of transcatheter closure of atrial septal defects in 400 patients. The primary objective was to identify predictive factors for procedural failure and to characterize the long-term clinical success following this routine intervention. Researchers defined the primary endpo

Welcome to Cardiology Today – Recorded October 17, 2025. This episode summarizes 5 key cardiology studies on topics like transthyretin cardiac amyloidosis and Neutrophil-to-lymphocyte ratio. Key takeaway: AI Echo Predicts Transthyretin Amyloid Outcomes. Article Links: Article 1: Prevalence and Associations of Systemic Inflammation in Heart Failure Across the Spectrum of Ejection Fraction. (JACC. Heart failure) Article 2: Prognostic Value of Papillary Muscle Scarring in Patients With Dilated Cardiomyopathy. (JAMA cardiology) Article 3: Neutrophil-to-lymphocyte ratio for risk stratification in acute myocarditis across the left ventricular ejection fraction spectrum. (European journal of heart failure) Article 4: Artificial intelligence-based echocardiographic assessment for monitoring disease progression in transthyretin cardiac amyloidosis. (European journal of heart failure) Article 5: Expression of Concern: Netrin-1 Preserves Blood-Brain Barrier Integrity Through Deleted in Colorectal Cancer/Focal Adhesion Kinase/RhoA Signaling Pathway Following Subarachnoid Hemorrhage in Rats. (Journal of the American Heart Association) Full episode page: https://podcast.explainheart.com/podcast/ai-echo-predicts-transthyretin-amyloid-outcomes-10-17-25/ Featured Articles Article 1: Prevalence and Associations of Systemic Inflammation in Heart Failure Across the Spectrum of Ejection Fraction. Journal: JACC. Heart failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41099689 Summary: This study characterized the prevalence and correlates of systemic inflammation across the spectrum of heart failure, including heart failure with reduced ejection fraction, heart failure with mildly reduced ejection fraction, and heart failure with preserved ejection fraction. It aimed to differentiate inflammatory mechanisms, where inflammation in heart failure with mildly reduced ejection fraction and heart failure with preserved ejection fraction is linked to cardiovascular-kidney-metabolic conditions. In contrast, inflammation in heart failure with reduced ejection fraction is thought to develop secondary to cardiac stress and circulatory derangements. This research establishes a crucial foundation for understanding distinct inflammatory profiles in varying heart failure phenotypes, which is vital for developing targeted therapeutic strategies. Article 2: Prognostic Value of Papillary Muscle Scarring in Patients With Dilated Cardiomyopathy. Journal: JAMA cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41091460 Summary: This cohort study was designed to investigate the prevalence and prognostic significance of papillary muscle scarring in patients with dilated cardiomyopathy. Recognizing that papillary muscle scarring can arise from microvascular dysfunction, even without epicardial coronary artery disease, the study aimed to establish whether this scarring is associated with adverse outcomes in this patient population. By clarifying the presence and impact of papillary muscle scarring in dilated cardiomyopathy, this research sought to provide crucial insights for enhanced risk stratification and personalized management strategies. The study thereby establishes a framework for future prognostic assessment in patients with dilated cardiomyopathy. Article 3: Neutrophil-to-lymphocyte ratio for risk stratification in acute myocarditis across the left ventricular ejection fraction spectrum. Journal: European journal of heart failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41098018 Summary: This study aimed to compare the predictive accuracy of various risk stratification models for acute myocarditis, with a specific focus on the utility of the neutrophil-to-lymphocyte ratio. The research recognized that the neutrophil-to-lymphocyte ratio (N.L.R.) is a valuable tool for risk stratification in patients with acute myocarditis, particularly addressing challenges in those presenting with preserved left ventricular ejection fraction (L.V.E.F.). By evaluating existing models and emphasizing the predictive power of N.L.R., this study significantly advances the ability to identify high-risk patients. These findings offer a more robust method for risk stratification in acute myocarditis across the left ventricular ejection fraction spectrum, enabling more precise clinical management and potentially improving patient outcomes. Article 4: Artificial intelligence-based echocardiographic assessment for monitoring disease progression in transthyretin cardiac amyloidosis. Journal: European journal of heart failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41098006 Summary: This study investigated artificial intelligence-based echocardiographic assessment for monitoring disease progression in transthyretin cardiac amyloidosis. Researchers conducted longitudinal transthoracic echocardiography on consecutive patients with transthyretin cardiac amyloidosis at baseline and 12-month follow-up, utilizing artificial intelligence for rapid and standardize

Welcome to Cardiology Today – Recorded October 16, 2025. This episode summarizes 5 key cardiology studies on topics like gene therapy and Adenosine Deaminase Deficiency. Key takeaway: New e.G.F.R. Threshold Refines HeF.pEF Diagnosis.. Article Links: Article 1: Long-Term Safety and Efficacy of Gene Therapy for Adenosine Deaminase Deficiency. (The New England journal of medicine) Article 2: Effects of Intensive Blood Pressure Control in Patients With Frailty: A Post Hoc Analysis From ESPRIT. (Journal of the American College of Cardiology) Article 3: Chronic Kidney Disease in Patients With Heart Failure With a Preserved Ejection Fraction: The Underlying Role of Visceral Adiposity. (Journal of the American College of Cardiology) Article 4: Atrial cardiomyopathy: markers and outcomes. (European heart journal) Article 5: Clonal Hematopoiesis and Cardiovascular Disease and Bleeding Risk and the Effectiveness of Aspirin. (JAMA cardiology) Full episode page: https://podcast.explainheart.com/podcast/new-e-g-f-r-threshold-refines-hef-pef-diagnosis-10-16-25/ Featured Articles Article 1: Long-Term Safety and Efficacy of Gene Therapy for Adenosine Deaminase Deficiency. Journal: The New England journal of medicine PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41092330 Summary: This study investigated the long-term safety and efficacy of gene therapy for Adenosine Deaminase Deficiency – Severe Combined Immunodeficiency, a life-threatening inborn error of immunity. Researchers treated patients with busulfan nonmyeloablative conditioning followed by transplantation of autologous C.D.34+ hematopoietic stem cells. These cells were transduced ex vivo with a lentiviral vector encoding human Adenosine Deaminase. The study aimed to establish the viability and outcomes of this advanced gene therapy approach for Adenosine Deaminase Deficiency – Severe Combined Immunodeficiency. Article 2: Effects of Intensive Blood Pressure Control in Patients With Frailty: A Post Hoc Analysis From ESPRIT. Journal: Journal of the American College of Cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41091084 Summary: This post hoc analysis from the ESPRIT trial aimed to characterize the benefit-harm profile of intensive blood pressure control in patients with varying degrees of frailty. Participants were categorized into nonfrail, moderately frail, and severely frail groups using the Rockwood cumulative deficit approach to calculate their baseline frailty index. The study sought to provide much-needed evidence on optimizing blood pressure management for this vulnerable population to improve clinical outcomes. Article 3: Chronic Kidney Disease in Patients With Heart Failure With a Preserved Ejection Fraction: The Underlying Role of Visceral Adiposity. Journal: Journal of the American College of Cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41091083 Summary: This study explored the underlying role of visceral adiposity in chronic kidney disease among patients with Heart Failure with Preserved Ejection Fraction, emphasizing the need for age-adjusted renal assessment. It established that the conventional estimated glomerular filtration rate threshold of less than 60 milliliters per minute per 1.73 meters squared often overlooks age-related physiological changes. The research proposed a more appropriate age-adjusted threshold of less than 45 milliliters per minute per 1.73 meters squared for identifying intrinsic renal disease in these patients. This refined diagnostic approach clarifies the prevalence of impaired kidney function and its link to visceral adiposity in Heart Failure with Preserved Ejection Fraction. Article 4: Atrial cardiomyopathy: markers and outcomes. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41092306 Summary: This study aimed to identify potential markers and risk factors for Atrial Cardiomyopathy and their associations with the incidence of Atrial Fibrillation, Heart Failure, and stroke. Utilizing data from the U.K. Biobank, researchers included individuals with cardiac magnetic resonance imaging and electrocardiographic information. The investigated Atrial Cardiomyopathy markers encompassed left atrial dilation, left atrial mechanical dysfunction, P-wave prolongation, and abnormal P-wave morphology. Establishing these associations could significantly enhance risk prediction and clinical management for patients susceptible to these cardiovascular complications. Article 5: Clonal Hematopoiesis and Cardiovascular Disease and Bleeding Risk and the Effectiveness of Aspirin. Journal: JAMA cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41091476 Summary: This prespecified substudy of the ASPREE trial investigated whether low-dose aspirin could benefit older adults with Clonal Hematopoiesis of Indeterminate Potential for the primary prevention of Cardiovascular Disease. Clonal Hematopoiesis of Indeterminate Potential is known to be associated with increased Cardiovascular D

Welcome to Cardiology Today – Recorded October 15, 2025. This episode summarizes 5 key cardiology studies on topics like nuclear imaging and transthyretin amyloid cardiomyopathy. Key takeaway: SCAI Stages Predict Cardiogenic Shock Risk. Article Links: Article 1: Haemodynamic effects of istaroxime in SCAI stage B HF-related cardiogenic shock: Insights from the SEISMiC trial. (ESC heart failure) Article 2: Prognostic impact of SCAI shock severity classes in AMI-related cardiogenic shock: A sub-study of the ECLS-SHOCK Trial. (ESC heart failure) Article 3: Nuclear imaging and echocardiographic findings in hypertrophic cardiomyopathy with and without ATTR-CM. (ESC heart failure) Article 4: Use of glucagon-like peptide-1 receptor agonists in patients with left ventricular assist devices. (ESC heart failure) Article 5: Dynamics of urinary chloride and sodium and their link to decongestion in acute heart failure and preserved ejection fraction: NACLOCRo-HF study. (ESC heart failure) Full episode page: https://podcast.explainheart.com/podcast/scai-stages-predict-cardiogenic-shock-risk-10-15-25/ Featured Articles Article 1: Haemodynamic effects of istaroxime in SCAI stage B HF-related cardiogenic shock: Insights from the SEISMiC trial. Journal: ESC heart failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41085472 Summary: The S.E.I.S.M.i.C. extension trial investigated the haemodynamic effects of istaroxime in S.C.A.I. stage B cardiogenic shock related to acute decompensated heart failure. Researchers randomized 30 patients to receive either placebo or istaroxime (0.5-1.0 micrograms per kilogram per minute) intravenously for 60 hours. This post-hoc analysis specifically assessed the impact of istaroxime on invasively obtained haemodynamic measures. The findings from this evaluation are crucial for understanding istaroxime’s potential role in managing cardiogenic shock and guiding future therapeutic paradigms. Article 2: Prognostic impact of SCAI shock severity classes in AMI-related cardiogenic shock: A sub-study of the ECLS-SHOCK Trial. Journal: ESC heart failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41083288 Summary: This sub-study of the E.C.L.S.-S.H.O.C.K. trial investigated the prognostic impact of S.C.A.I. shock severity classes in acute myocardial infarction-related cardiogenic shock. Researchers aimed to clarify how S.C.A.I. stages influence the effectiveness of extracorporeal life support therapy in these patients. The study establishes the critical role of S.C.A.I. classification for risk stratification in acute myocardial infarction complicated by cardiogenic shock. These findings provide a more nuanced understanding of prognosis and treatment response in this high-risk population, guiding personalized therapeutic approaches. Article 3: Nuclear imaging and echocardiographic findings in hypertrophic cardiomyopathy with and without ATTR-CM. Journal: ESC heart failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41081448 Summary: This study assessed the frequency of planar scintigraphy, with and without single-photon emission computed tomography, in hypertrophic cardiomyopathy patients screened for transthyretin amyloid cardiomyopathy in the T.T.R.A.C.K. study. It addressed variability in readings across different cardiac nuclear imaging tests, radiotracers, and readers, as well as discrepancies in echocardiographic findings. By evaluating these diagnostic methodologies, the research provides valuable insights into optimizing the identification of transthyretin amyloid cardiomyopathy. This work ultimately aims to reduce diagnostic delays, which significantly impact patient outcomes. Article 4: Use of glucagon-like peptide-1 receptor agonists in patients with left ventricular assist devices. Journal: ESC heart failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41078121 Summary: This retrospective cohort study evaluated the association of glucagon-like peptide-1 receptor agonist therapy with cardiovascular outcomes in patients with left ventricular assist devices. Left ventricular assist devices are vital for advanced heart failure, and obesity and diabetes are known to impact patient outcomes. By investigating the role of glucagon-like peptide-1 receptor agonists, which have demonstrated cardiovascular benefits, this research addresses a previously underexplored therapeutic area. The findings provide crucial information for optimizing medical management and potentially improving long-term outcomes for patients supported by left ventricular assist devices. Article 5: Dynamics of urinary chloride and sodium and their link to decongestion in acute heart failure and preserved ejection fraction: NACLOCRo-HF study. Journal: ESC heart failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41078081 Summary: The N.A.C.L.O.C.R.o.-H.F. study prospectively examined the trajectories of urinary chloride and urinary sodium during acute heart failure hospitalization in elderly patients with heart failure with p

Welcome to Cardiology Today – Recorded October 15, 2025. This episode summarizes 5 key cardiology studies on topics like Systematic COronary Risk Evaluation 2 and bradyarrhythmias. Key takeaway: AI ECG Boosts Hypertrophic Cardiomyopathy Detection.. Article Links: Article 1: Left atrial pressure normalisation by graded radiofrequency atrial septostomy in heart failure with preserved ejection fraction: a single-arm pilot study. (Heart (British Cardiac Society)) Article 2: Retinal image-based deep learning for mild cognitive impairment detection in coronary artery disease population. (Heart (British Cardiac Society)) Article 3: Predictive performance of cardiovascular disease risk prediction models in older adults: a validation and updating study. (Heart (British Cardiac Society)) Article 4: Clinical implementation of an AI-enabled ECG for hypertrophic cardiomyopathy detection. (Heart (British Cardiac Society)) Article 5: Pacemaker implantation after cardiac surgery: a contemporary, nationwide perspective. (Heart (British Cardiac Society)) Full episode page: https://podcast.explainheart.com/podcast/ai-ecg-boosts-hypertrophic-cardiomyopathy-detection-10-15-25/ Featured Articles Article 1: Left atrial pressure normalisation by graded radiofrequency atrial septostomy in heart failure with preserved ejection fraction: a single-arm pilot study. Journal: Heart (British Cardiac Society) PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40425275 Summary: This single-arm pilot study explored the use of a personalized approach, combining radiofrequency ablation and balloon dilation (C.U.R.B.), to establish interatrial communication in patients with Heart Failure with Preserved Ejection Fraction. The research was conducted at Fuwai Hospital in patients exhibiting elevated resting mean left atrial pressure of 18 millimeters of mercury or higher. This study aimed to normalize left atrial pressure, offering a potential new therapeutic strategy for Heart Failure with Preserved Ejection Fraction management. It successfully investigated the methodology for this intervention, providing a foundation for future larger studies on its efficacy and safety. Article 2: Retinal image-based deep learning for mild cognitive impairment detection in coronary artery disease population. Journal: Heart (British Cardiac Society) PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40379470 Summary: This study aimed to develop a deep learning model based on retinal fundus images for optimized detection of mild cognitive impairment in individuals with Coronary Artery Disease. The research involved Coronary Artery Disease patients, defined by at least one 50 percent stenosis, from Beijing Anzhen Hospital between 2021 and 2023. This methodology establishes a non-invasive approach to screen for mild cognitive impairment, which is commonly associated with Coronary Artery Disease. The development of such a model could facilitate early intervention and improve prognostic outcomes for this vulnerable patient group. Article 3: Predictive performance of cardiovascular disease risk prediction models in older adults: a validation and updating study. Journal: Heart (British Cardiac Society) PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40368453 Summary: This study aimed to validate, update, and assess the utility of several prominent Cardiovascular Disease risk prediction models in an Australian older adult population. Researchers specifically evaluated models originally developed for middle-aged individuals, such as the American College of Cardiology/American Heart Association and 2008 Framingham models, alongside an age-specific Systematic COronary Risk Evaluation 2-Older Person model. The methodology established a comprehensive framework for assessing these models’ predictive performance in older adults. This research addresses current inadequacies in risk prediction for the elderly, contributing to improved, age-appropriate prevention strategies for Cardiovascular Disease. Article 4: Clinical implementation of an AI-enabled ECG for hypertrophic cardiomyopathy detection. Journal: Heart (British Cardiac Society) PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40240132 Summary: for hypertrophic cardiomyopathy detection. This open-label, multicenter prospective cohort study assessed the clinical implementation of an Artificial Intelligence-enabled 12-lead electrocardiogram software for detecting suspected Hypertrophic Cardiomyopathy. The Viz H.C.M. (Viz.ai) software, which alerts clinicians to potential Hypertrophic Cardiomyopathy cases, was implemented across five healthcare systems from January to December 2023. This research successfully demonstrated the real-world utility of A.I.-E.C.G. tools in assisting with early patient identification and evaluation. The findings offer a pathway to improve diagnosis rates for this often underdiagnosed cardiac condition. Article 5: Pacemaker implantation after cardiac surgery: a contemporary, nationwide perspective. Journal: He

Welcome to Cardiology Today – Recorded October 14, 2025. This episode summarizes 5 key cardiology studies on topics like C.O.V.I.D.-19 and Low-density lipoprotein cholesterol. Key takeaway: LDL, Lp(a), CRP: Independent CV Event Predictors.. Article Links: Article 1: Accelerated vascular ageing after COVID-19 infection: the CARTESIAN study. (European heart journal) Article 2: Heparin administration at first medical contact vs immediately before primary percutaneous coronary intervention: the HELP-PCI trial. (European heart journal) Article 3: Low-density lipoprotein cholesterol, lipoprotein(a) and high-sensitivity C-reactive protein are independent predictors of cardiovascular events. (European heart journal) Article 4: Low-density lipoprotein cholesterol, C-reactive protein, and lipoprotein(a) universal one-time screening in primary prevention: the EPIC-Norfolk study. (European heart journal) Article 5: DanGer shock criteria and outcomes in acute myocardial infarction-related cardiogenic shock treated with Impella: the J-PVAD registry. (European heart journal) Full episode page: https://podcast.explainheart.com/podcast/ldl-lpa-crp-independent-cv-event-predictors-10-14-25/ Featured Articles Article 1: Accelerated vascular ageing after COVID-19 infection: the CARTESIAN study. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40819656 Summary: The C.A.R.T.E.S.I.A.N. study, a prospective, multicentric cohort investigation across 16 countries, confirmed accelerated vascular aging following C.O.V.I.D.-19 infection. By comparing C.O.V.I.D.-19-negative controls with individuals 6 ± 3 months post-infection, the study established a significant link between the virus and long-term vascular damage. These findings underscore the importance of long-term cardiovascular monitoring in C.O.V.I.D.-19 survivors due to an increased risk of complications. Article 2: Heparin administration at first medical contact vs immediately before primary percutaneous coronary intervention: the HELP-PCI trial. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40748607 Summary: trial. The H.E.L.P.-P.C.I. trial, an investigator-initiated randomized controlled study, investigated the optimal timing for unfractionated heparin administration in patients with S.T.-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Patients were randomized to receive unfractionated heparin either at first medical contact or immediately before the procedure. The abstract describes the study’s design and rationale, addressing the clinical uncertainty regarding the efficacy of pre-treatment, but the specific trial results or conclusions are not provided within the abstract itself. Article 3: Low-density lipoprotein cholesterol, lipoprotein(a) and high-sensitivity C-reactive protein are independent predictors of cardiovascular events. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40320753 Summary: This U.K. Biobank analysis of 322,922 participants revealed that low-density lipoprotein cholesterol, lipoprotein(a), and high-sensitivity C-reactive protein are independent predictors of incident major adverse cardiovascular events. The study demonstrated these biomarkers’ associations, both individually and in combination, with cardiovascular outcomes, irrespective of cholesterol-lowering medication status. These findings support the utility of assessing these three markers for robust cardiovascular risk stratification. Article 4: Low-density lipoprotein cholesterol, C-reactive protein, and lipoprotein(a) universal one-time screening in primary prevention: the EPIC-Norfolk study. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40167249 Summary: The E.P.I.C.-Norfolk study investigated the validity and generalizability of a proposed universal one-time screening strategy for low-density lipoprotein cholesterol, high-sensitivity C-reactive protein, and lipoprotein(a) in primary prevention. This prospective European cohort enrolled 17,087 initially healthy participants, measuring these biomarkers at study entry. The abstract highlights the study’s aim to validate previous findings from an American cohort, but it does not present the specific outcomes or conclusions from the E.P.I.C.-Norfolk analysis itself. Article 5: DanGer shock criteria and outcomes in acute myocardial infarction-related cardiogenic shock treated with Impella: the J-PVAD registry. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41078250 Summary: registry. The J-P.V.A.D. registry study aimed to evaluate outcomes in acute myocardial infarction-related cardiogenic shock patients treated with Impella, stratified by DanGer shock eligibility criteria. Analyzing 3975 patients from a nationwide Japanese registry, the study sought to understand the real-world distribution and efficacy of Impella use beyond the highly selecte

Welcome to Cardiology Today – Recorded October 14, 2025. This episode summarizes 5 key cardiology studies on topics like Ascending Aortic Diameter and Bleeding Events. Key takeaway: HeartMate 3 Reduces L.V.A.D. Thromboembolism. Article Links: Article 1: Effect of Dapagliflozin on Quality of Life of Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation. (Journal of the American College of Cardiology) Article 2: Clonal Hematopoiesis and Cardiovascular Outcomes in Older Women. (Journal of the American College of Cardiology) Article 3: Trade-Off Between Bleeding and Ischemic Events From Left Ventricular Assist Devices: A EUROMACS Registry Analysis. (Journal of the American College of Cardiology) Article 4: Transcatheter Closure of Patent Foramen Ovale With a Novel Biodegradable Device: A Prospective, Multicenter, Randomized Controlled Clinical Trial. (Circulation) Article 5: Sex differences in ascending aortic diameter at the time of acute type A aortic dissection. (Heart (British Cardiac Society)) Full episode page: https://podcast.explainheart.com/podcast/heartmate-3-reduces-l-v-a-d-thromboembolism-10-14-25/ Featured Articles Article 1: Effect of Dapagliflozin on Quality of Life of Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation. Journal: Journal of the American College of Cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41062227 Summary: Article number one. Effect of Dapagliflozin on Quality of Life of Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation. Article 2: Clonal Hematopoiesis and Cardiovascular Outcomes in Older Women. Journal: Journal of the American College of Cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40864016 Summary: Article number two. Clonal Hematopoiesis and Cardiovascular Outcomes in Older Women. Article 3: Trade-Off Between Bleeding and Ischemic Events From Left Ventricular Assist Devices: A EUROMACS Registry Analysis. Journal: Journal of the American College of Cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40864013 Summary: Article number three. Trade-Off Between Bleeding and Ischemic Events From Left Ventricular Assist Devices: A EUROMACS Registry Analysis. Article 4: Transcatheter Closure of Patent Foramen Ovale With a Novel Biodegradable Device: A Prospective, Multicenter, Randomized Controlled Clinical Trial. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41078120 Summary: Article number four. Transcatheter Closure of Patent Foramen Ovale With a Novel Biodegradable Device: A Prospective, Multicenter, Randomized Controlled Clinical Trial. Article 5: Sex differences in ascending aortic diameter at the time of acute type A aortic dissection. Journal: Heart (British Cardiac Society) PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41083213 Summary: Article number five. Sex differences in ascending aortic diameter at the time of acute type A aortic dissection. Transcript Today’s date is October 14, 2025. Welcome to Cardiology Today. Here are the latest research findings. Article number one. Effect of Dapagliflozin on Quality of Life of Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation. Article number two. Clonal Hematopoiesis and Cardiovascular Outcomes in Older Women. Article number three. Trade-Off Between Bleeding and Ischemic Events From Left Ventricular Assist Devices: A EUROMACS Registry Analysis. Article number four. Transcatheter Closure of Patent Foramen Ovale With a Novel Biodegradable Device: A Prospective, Multicenter, Randomized Controlled Clinical Trial. Article number five. Sex differences in ascending aortic diameter at the time of acute type A aortic dissection. Thank you for listening. Don’t forget to subscribe. Keywords Ascending Aortic Diameter, Bleeding Events, EUROMACS Registry, Acute Type A Aortic Dissection, Dapagliflozin, Women’s Health Initiative, Biodegradable Device, Left Ventricular Assist Device, Ischemic Events, High-Coverage Sequencing, Randomized Clinical Trial, Cardiovascular Disease, HeartMate 3, Heart Failure, Older Women, Computed Tomography Scan, Nitinol Device, Transcatheter Aortic Valve Implantation, Clonal Hematopoiesis of Indeterminate Potential, Patent Foramen Ovale, Aortic Aneurysm, Quality of Life, Sex Differences, Aortic Stenosis, Transcatheter Closure. About Concise summaries of cardiovascular research for professionals. Subscribe • Share • FollowThe post HeartMate 3 Reduces L.V.A.D. Thromboembolism 10/14/25 first appeared on Cardiology Today.

Welcome to Cardiology Today – Recorded October 13, 2025. This episode summarizes 5 key cardiology studies on topics like Ryanodine receptor type-2 and Aortic arch morphology. Key takeaway: New Monocyte Role in Aortic Stenosis & Fibrosis. Article Links: Article 1: Aortic Arch Morphology and Cerebrovascular Accidents after Transfemoral Transcatheter Aortic Valve Implantation. (The American journal of cardiology) Article 2: Monocytes at the crossroads of aortic stenosis and myocardial damage. (Cardiovascular research) Article 3: Cardiovascular risk factors and the allostatic interoceptive network in dementia. (Cardiovascular research) Article 4: Activated CaMKIIδ translocates to the RyR nanodomain in cardiomyocytes. (Cardiovascular research) Article 5: Multicenter Pivotal Trial of the Minima Stent for Vascular Stenosis in Infants and Young Children. (Circulation. Cardiovascular interventions) Full episode page: https://podcast.explainheart.com/podcast/new-monocyte-role-in-aortic-stenosis-fibrosis-10-13-25/ Featured Articles Article 1: Aortic Arch Morphology and Cerebrovascular Accidents after Transfemoral Transcatheter Aortic Valve Implantation. Journal: The American journal of cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41077218 Summary: This study investigates the impact of aortic arch morphology, including arch angle, calcification, and soft plaques, on the incidence of cerebrovascular accidents (C.V.A.) following transfemoral transcatheter aortic valve implantation (T.A.V.I.). This analysis uses pre-procedural computed tomography (C.T.) scans from consecutive patients. The abstract describes the study’s objective and methodology, which includes patient analysis up to January 2025, but does not present specific findings or clinical outcomes. Article 2: Monocytes at the crossroads of aortic stenosis and myocardial damage. Journal: Cardiovascular research PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41073370 Summary: This research highlights the critical role of monocytes in aortic stenosis (A.S.) progression and associated myocardial damage. Previous work from this group identified a specific monocyte subpopulation implicated in both valvular calcification and myocardial fibrosis. This subpopulation mediates crucial crosstalk between the aortic valve and the myocardium, suggesting a novel mechanistic link between inflammation and structural heart disease. Article 3: Cardiovascular risk factors and the allostatic interoceptive network in dementia. Journal: Cardiovascular research PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41073365 Summary: This study aims to elucidate how established cardiovascular risk factors, such as diabetes, hypertension, obesity, and smoking, influence the Allostatic-Interoceptive Network (A.I.N.) in the context of dementia. The A.I.N. is crucial for continuous monitoring of internal bodily states and is known to be vulnerable to neurodegeneration. While the abstract outlines the significant research question, it does not present the specific findings or conclusions of this investigation. Article 4: Activated CaMKIIδ translocates to the RyR nanodomain in cardiomyocytes. Journal: Cardiovascular research PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41071938 Summary: This study investigates the precise spatial recruitment and anchoring mechanisms of activated Ca2+/calmodulin-dependent kinase I.I. delta (CaMKIIδ) to the ryanodine receptor type-2 (R.Y.R.) nanodomain in cardiomyocytes. This interaction is critical for regulating calcium release, which is fundamental to the heartbeat, with hyperphosphorylation leading to pathological calcium release. The abstract describes the study’s objective and methods, including confocal and dSTORM microscopy, but does not provide the actual findings or conclusions regarding these molecular mechanisms. Article 5: Multicenter Pivotal Trial of the Minima Stent for Vascular Stenosis in Infants and Young Children. Journal: Circulation. Cardiovascular interventions PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41070410 Summary: This multicenter, single-arm, prospective trial evaluated the safety and efficacy of the Minima Stent System, the first Food and Drug Administration (F.D.A.)-approved stent specifically designed for neonates, infants, and children. The study targeted vascular stenosis in pulmonary artery stenosis (P.A.S.) and coarctation of the aorta (C.o.A.). While the abstract outlines the trial’s design and primary endpoints, it does not present the specific clinical outcomes, efficacy rates, or safety profiles from the completed trial. Transcript Today’s date is October 13, 2025. Welcome to Cardiology Today. Here are the latest research findings. Article number one. Aortic Arch Morphology and Cerebrovascular Accidents after Transfemoral Transcatheter Aortic Valve Implantation. This study investigates the impact of aortic arch morphology, including arch angle, calcification, and soft plaques, on the incidence

Welcome to Cardiology Today – Recorded October 13, 2025. This episode summarizes 5 key cardiology studies on topics like symptomatic atrial fibrillation and coronary sinus pacing. Key takeaway: Ibrutinib Raises Sudden Cardiac Death Risk.. Article Links: Article 1: Sudden Death and Asymptomatic Arrhythmia in Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib. (Heart rhythm) Article 2: Insulin sensitivity, genetic predisposition, and risk of atrial fibrillation: a prospective cohort study. (Heart rhythm) Article 3: Alternative Pacing Strategies Following Transcatheter Tricuspid Valve Interventions: Procedural Challenges and Lessons Learned. (Heart rhythm) Article 4: Questioning the Role of Pulmonary Vein Isolation in Multimorbid Patients: A Prospective Analysis in Over 1,400 AF Patients. (Heart rhythm) Article 5: Asymptomatic Atrial Fibrillation: Clinical Characteristics, Outcomes, and Prognostic Impact of Rhythm Control. (Heart rhythm) Full episode page: https://podcast.explainheart.com/podcast/ibrutinib-raises-sudden-cardiac-death-risk-10-13-25/ Featured Articles Article 1: Sudden Death and Asymptomatic Arrhythmia in Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib. Journal: Heart rhythm PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41077373 Summary: Article number one. Sudden Death and Asymptomatic Arrhythmia in Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib. Article 2: Insulin sensitivity, genetic predisposition, and risk of atrial fibrillation: a prospective cohort study. Journal: Heart rhythm PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41077371 Summary: Article number two. Insulin sensitivity, genetic predisposition, and risk of atrial fibrillation: a prospective cohort study. Article 3: Alternative Pacing Strategies Following Transcatheter Tricuspid Valve Interventions: Procedural Challenges and Lessons Learned. Journal: Heart rhythm PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41077369 Summary: Article number three. Alternative Pacing Strategies Following Transcatheter Tricuspid Valve Interventions: Procedural Challenges and Lessons Learned. Article 4: Questioning the Role of Pulmonary Vein Isolation in Multimorbid Patients: A Prospective Analysis in Over 1,400 AF Patients. Journal: Heart rhythm PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41077368 Summary: Article number four. Questioning the Role of Pulmonary Vein Isolation in Multimorbid Patients: A Prospective Analysis in Over 1,400 A.fib Patients. Article 5: Asymptomatic Atrial Fibrillation: Clinical Characteristics, Outcomes, and Prognostic Impact of Rhythm Control. Journal: Heart rhythm PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41077365 Summary: Article number five. Asymptomatic Atrial Fibrillation: Clinical Characteristics, Outcomes, and Prognostic Impact of Rhythm Control. Transcript Today’s date is October 13, 2025. Welcome to Cardiology Today. Here are the latest research findings. Article number one. Sudden Death and Asymptomatic Arrhythmia in Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib. Article number two. Insulin sensitivity, genetic predisposition, and risk of atrial fibrillation: a prospective cohort study. Article number three. Alternative Pacing Strategies Following Transcatheter Tricuspid Valve Interventions: Procedural Challenges and Lessons Learned. Article number four. Questioning the Role of Pulmonary Vein Isolation in Multimorbid Patients: A Prospective Analysis in Over 1,400 A.fib Patients. Article number five. Asymptomatic Atrial Fibrillation: Clinical Characteristics, Outcomes, and Prognostic Impact of Rhythm Control. Thank you for listening. Don’t forget to subscribe. Keywords symptomatic atrial fibrillation, coronary sinus pacing, transcatheter tricuspid valve replacement, catheter ablation, rhythm control, clinical outcomes, Bruton’s tyrosine kinase inhibitor, transcatheter edge-to-edge repair, multimorbidity, European Heart Rhythm Association, prognosis, atrial fibrillation, arrhythmias, pulmonary vein isolation, China-A.F. registry, Ibrutinib, sudden cardiac death, cardiac pacing, U.K. Biobank, leadless pacemaker, estimated glucose disposal rate, prospective cohort study, genetic predisposition, early rhythm control, antiarrhythmic drugs, asymptomatic atrial fibrillation, transcatheter tricuspid valve intervention, chronic lymphocytic leukemia, insulin sensitivity. About Concise summaries of cardiovascular research for professionals. Subscribe • Share • FollowThe post Ibrutinib Raises Sudden Cardiac Death Risk. 10/13/25 first appeared on Cardiology Today.

Welcome to Cardiology Today – Recorded October 12, 2025. This episode summarizes 5 key cardiology studies on topics like social vulnerability and lung development. Key takeaway: Mineralocorticoid Antagonists Cut Postoperative A. fib.. Article Links: Article 1: Prolonged Postnatal Hypoxia Impairs Lung Development and Causes Severe Pulmonary Hypertension in Mice. (Journal of the American Heart Association) Article 2: Endothelial Cell-Related Proteins in Plasma Predict Major Adverse Cardiovascular Events and Worsening Heart Failure in Patients With Hypertrophic Cardiomyopathy. (Journal of the American Heart Association) Article 3: Listing for Pediatric Donation After Circulatory Death Heart Transplantation Is Associated With Improved Waitlist Outcomes. (Journal of the American Heart Association) Article 4: Mineralocorticoid Receptor Antagonism Reduces Atrial Arrhythmias Post-Cardiac Surgery and Attenuates Atrial Stress Responses to Cardioplegic Arrest. (Journal of the American Heart Association) Article 5: Disparities in Geographic Access to Cardiac Rehabilitation Among Socially Vulnerable Communities. (Journal of the American Heart Association) Full episode page: https://podcast.explainheart.com/podcast/mineralocorticoid-antagonists-cut-postoperative-a-fib-10-12-25/ Featured Articles Article 1: Prolonged Postnatal Hypoxia Impairs Lung Development and Causes Severe Pulmonary Hypertension in Mice. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41065255 Summary: This study established a novel mouse model for pediatric pulmonary hypertension by exposing C57bl/6J mice to prolonged postnatal normobaric hypoxia at 11 percent inspired fraction of oxygen. Unlike previous transient hypoxia models, this approach successfully induced severe pulmonary hypertension and impaired lung development, accurately replicating the pathological conditions observed in children living at high altitude. This model provides a critical tool for investigating the pathogenesis of pediatric pulmonary hypertension and evaluating new therapeutic strategies. Article 2: Endothelial Cell-Related Proteins in Plasma Predict Major Adverse Cardiovascular Events and Worsening Heart Failure in Patients With Hypertrophic Cardiomyopathy. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41065251 Summary: In a prospective cohort study, researchers measured plasma levels of 90 endothelial cell-related proteins in patients with hypertrophic cardiomyopathy upon enrollment. The study identified specific endothelial cell-related proteins that accurately predict major adverse cardiovascular events and worsening heart failure. These findings highlight the significant prognostic value of endothelial dysfunction in hypertrophic cardiomyopathy, offering potential novel biomarkers for risk stratification and personalized management strategies. Article 3: Listing for Pediatric Donation After Circulatory Death Heart Transplantation Is Associated With Improved Waitlist Outcomes. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41065250 Summary: This study analyzed the United Network for Organ Sharing database, comparing waitlist outcomes for pediatric heart transplant candidates listed for donation after brain death versus donation after circulatory death hearts. The findings revealed that listing for donation after circulatory death heart transplantation was associated with significantly improved waitlist outcomes, including reduced waitlist mortality and a higher rate of transplantation. This indicates that expanding the donor pool to include donation after circulatory death hearts is a vital strategy to address the critical organ shortage and improve survival for pediatric heart transplant recipients. Article 4: Mineralocorticoid Receptor Antagonism Reduces Atrial Arrhythmias Post-Cardiac Surgery and Attenuates Atrial Stress Responses to Cardioplegic Arrest. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41065249 Summary: This study investigated 19,042 cardiac surgery patients, using propensity matching to compare outcomes in mineralocorticoid receptor antagonist users and non-users. Preoperative use of mineralocorticoid receptor antagonists significantly reduced the incidence of postoperative atrial fibrillation. Furthermore, a subgroup analysis demonstrated that these antagonists attenuated atrial stress responses to cardioplegic arrest, modulating specific atrial cell types during cold preservation. These findings suggest mineralocorticoid receptor antagonists represent a promising prophylactic strategy to prevent postoperative atrial fibrillation. Article 5: Disparities in Geographic Access to Cardiac Rehabilitation Among Socially Vulnerable Communities. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41065247 Summary: This st

Welcome to Cardiology Today – Recorded October 12, 2025. This episode summarizes 5 key cardiology studies on topics like Pulmonary disease and risk factors. Key takeaway: C.M.R. Strain Boosts H.C.M. Sudden Death Risk. Article Links: Article 1: Primary Graft Dysfunction in Patients Supported With Durable Left Ventricular Assist Devices Before Heart Transplantation. (JACC. Heart failure) Article 2: Long-Term Outcomes in Women With a History of Peripartum Cardiomyopathy. (JACC. Heart failure) Article 3: The association between polypharmacy and mortality in patients with heart failure: Results from the PULSE dataset. (ESC heart failure) Article 4: Feature Tracking-Derived Global Longitudinal Strain Enhances Risk Stratification for Sudden Cardiac Death in Hypertrophic Cardiomyopathy. (JACC. Cardiovascular imaging) Article 5: Impact of Pulmonary Disease on Clinical Outcomes in Patients Undergoing Mitral Valve Edge-to-Edge Repair. (The American journal of cardiology) Full episode page: https://podcast.explainheart.com/podcast/c-m-r-strain-boosts-h-c-m-sudden-death-risk-10-12-25/ Featured Articles Article 1: Primary Graft Dysfunction in Patients Supported With Durable Left Ventricular Assist Devices Before Heart Transplantation. Journal: JACC. Heart failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41074902 Summary: This study leveraged data from the International Consortium on Primary Graft Dysfunction to quantify outcomes and identify clinical risk factors for severe primary graft dysfunction in patients with durable Left Ventricular Assist Device support prior to heart transplantation. Building upon previous single-center studies, it identified trends and specific risk factors. The findings from this large consortium study will likely improve risk stratification and management strategies for this high-risk patient population undergoing heart transplantation. Article 2: Long-Term Outcomes in Women With a History of Peripartum Cardiomyopathy. Journal: JACC. Heart failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41074900 Summary: This prospective study followed 96 women with peripartum cardiomyopathy for at least three years, providing crucial long-term outcome data which has previously been limited. Researchers evaluated the clinical course and echocardiographic parameters in these patients, who were diagnosed at a mean age of 31.6 years. The findings offer valuable insights into the prognosis and long-term management of peripartum cardiomyopathy, informing care strategies for affected women. Article 3: The association between polypharmacy and mortality in patients with heart failure: Results from the PULSE dataset. Journal: ESC heart failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41074682 Summary: dataset. This retrospective observational cohort study utilized the P.U.L.S.E. dataset to investigate the association between polypharmacy and mortality in patients hospitalized for heart failure. Analyzing medication data from admission and discharge, researchers employed Cox proportional hazard models to explore this relationship. The study’s findings reveal a significant association between polypharmacy and mortality, underscoring the importance of medication review and optimization in this vulnerable patient population. Article 4: Feature Tracking-Derived Global Longitudinal Strain Enhances Risk Stratification for Sudden Cardiac Death in Hypertrophic Cardiomyopathy. Journal: JACC. Cardiovascular imaging PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41074892 Summary: This study demonstrated that Left Ventricular Global Longitudinal Strain, derived from Cardiac Magnetic Resonance feature tracking, significantly enhances risk stratification for sudden cardiac death in patients with hypertrophic cardiomyopathy. This marker provides incremental prognostic value beyond established European Society of Cardiology and American College of Cardiology/American Heart Association guidelines. The findings suggest that incorporating Left Ventricular Global Longitudinal Strain assessment could lead to more precise identification of high-risk patients, guiding more targeted interventions and improving clinical outcomes. Article 5: Impact of Pulmonary Disease on Clinical Outcomes in Patients Undergoing Mitral Valve Edge-to-Edge Repair. Journal: The American journal of cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41075959 Summary: This study investigated the impact of pulmonary disease on clinical outcomes in 3,666 patients undergoing mitral transcatheter edge-to-edge repair, stratifying them by the presence or absence of pulmonary disease. The findings indicate that co-existing pulmonary disease significantly influences all-cause mortality following the procedure, as evaluated using Kaplan-Meier analysis. This highlights the importance of comprehensive pre-procedural assessment and risk stratification, potentially guiding patient selection and management strategies for mitral transcatheter edge-to-edge rep

Welcome to Cardiology Today – Recorded October 11, 2025. This episode summarizes 5 key cardiology studies on topics like cardiometabolic risk factors and metabolomic biomarkers. Key takeaway: Metabolomic Biomarkers Predict C.A.D. Events. Article Links: Article 1: Normobaric Hyperoxia in Patients With Acute Stroke: Enhancing Neuroprotection Through Inhibition of Inflammation. (Journal of the American Heart Association) Article 2: Longitudinal Intracardiac Right Ventricular Flow Analysis in Infants With Hypoplastic Left Heart Syndrome in Interstage I Using Novel Doppler Velocity Reconstruction. (Journal of the American Heart Association) Article 3: Metabolomic Biomarkers Are Independently Associated With Secondary Adverse Cardiovascular Events in Patients With Coronary Artery Disease. (Journal of the American Heart Association) Article 4: Lifetime Exposure to Violence and Early Cardiometabolic Risk Factors in a Healthy Swedish Cohort. (Journal of the American Heart Association) Article 5: Competing Risks of Cardiac and Noncardiac Mortality in Patients With Secondary Mitral Regurgitation Undergoing Transcatheter Edge-to-Edge Repair. (Journal of the American Heart Association) Full episode page: https://podcast.explainheart.com/podcast/metabolomic-biomarkers-predict-c-a-d-events-10-11-25/ Featured Articles Article 1: Normobaric Hyperoxia in Patients With Acute Stroke: Enhancing Neuroprotection Through Inhibition of Inflammation. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41065265 Summary: This study describes a secondary analysis of the O.P.E.N.S. (Normobaric Hyperoxia Combined With Reperfusion for Acute Ischemic Stroke) trial, involving 86 acute ischemic stroke patients with anterior circulation occlusion. The aim was to investigate the effects of normobaric hyperoxia on the inflammatory response and its role in stroke-induced brain injury. However, the provided abstract does not detail the specific findings, conclusions, or clinical implications of this investigation. Article 2: Longitudinal Intracardiac Right Ventricular Flow Analysis in Infants With Hypoplastic Left Heart Syndrome in Interstage I Using Novel Doppler Velocity Reconstruction. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41065263 Summary: This study aimed to analyze longitudinal changes in right ventricular intracardiac flow in infants with hypoplastic left heart syndrome during the critical interstage period. Researchers utilized a novel Doppler velocity reconstruction method to quantify kinetic energy, vortex strength, and flow energy loss from conventional color Doppler acquisitions. While the study hypothesized about these changes, the provided abstract does not present the specific findings or conclusions regarding the actual measurements or their clinical significance in this patient population. Article 3: Metabolomic Biomarkers Are Independently Associated With Secondary Adverse Cardiovascular Events in Patients With Coronary Artery Disease. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41065262 Summary: This study analyzed 249 plasma metabolites in 10,175 U.K. Biobank participants with coronary artery disease to identify potential biomarkers for secondary major adverse cardiovascular events. Using nuclear magnetic resonance and elastic net regression models, the research established that specific metabolomic biomarkers are independently associated with an increased risk of future cardiovascular events. This suggests their potential utility in enhancing risk prediction and guiding preventive strategies in patients already diagnosed with coronary artery disease. Article 4: Lifetime Exposure to Violence and Early Cardiometabolic Risk Factors in a Healthy Swedish Cohort. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41065261 Summary: This study investigated the association between lifetime exposure to violence and early cardiometabolic risk factors in 23,215 healthy Swedish adults aged 18 to 50 years from the LifeGene study. Participants reported on physical and sexual violence exposure, alongside medical diagnoses of hypertension, diabetes, dyslipidemia, and smoking history. However, the provided abstract outlines the study’s scope and methods but does not detail the specific findings or conclusions regarding the observed associations or potential sex differences. Article 5: Competing Risks of Cardiac and Noncardiac Mortality in Patients With Secondary Mitral Regurgitation Undergoing Transcatheter Edge-to-Edge Repair. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41065256 Summary: This study utilized data from the G.I.O.T.T.O. (Italian Society of Interventional Cardiology [GIse] Registry Of Transcatheter Treatment of Mitral Regurgitation) registry to assess the competing risks and in

Welcome to Cardiology Today – Recorded October 11, 2025. This episode summarizes 5 key cardiology studies on topics like sleep apnea and P.A.R.A.G.O.N.-H.F. trial. Key takeaway: P.F.A. Breakthrough for Scar V.T. Ablation. Article Links: Article 1: High-Voltage Focal Pulsed Field Ablation to Treat Scar-Related Ventricular Tachycardia: The First-in-Human VCAS Trial. (Circulation) Article 2: Pregnancy after lung transplantation: TRIGGER study on anti-human leucocyte antigen alloimmunization and antibody-mediated rejection risk. (The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation) Article 3: Outcomes of Central versus Peripheral Arterial Cannulation for Intraoperative Extracorporeal Membrane Oxygenation Support in Lung Transplantation. (The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation) Article 4: Sleep Apnea and Cardiac Structure and Function in Patients with Heart Failure with Preserved Ejection Fraction: Insights from the PARAGON-HF Trial. (Journal of cardiac failure) Article 5: Sex-Specific Cardiovascular Consequences of Long-Term High-Salt Diet in Mice. (Journal of the American Heart Association) Full episode page: https://podcast.explainheart.com/podcast/p-f-a-breakthrough-for-scar-v-t-ablation-10-11-25/ Featured Articles Article 1: High-Voltage Focal Pulsed Field Ablation to Treat Scar-Related Ventricular Tachycardia: The First-in-Human VCAS Trial. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41071961 Summary: Article number one. High-Voltage Focal Pulsed Field Ablation to Treat Scar-Related Ventricular Tachycardia: The First-in-Human VCAS Trial. Article 2: Pregnancy after lung transplantation: TRIGGER study on anti-human leucocyte antigen alloimmunization and antibody-mediated rejection risk. Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41072744 Summary: Article number two. Pregnancy after lung transplantation: TRIGGER study on anti-human leucocyte antigen alloimmunization and antibody-mediated rejection risk. Article 3: Outcomes of Central versus Peripheral Arterial Cannulation for Intraoperative Extracorporeal Membrane Oxygenation Support in Lung Transplantation. Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41072743 Summary: Article number three. Outcomes of Central versus Peripheral Arterial Cannulation for Intraoperative Extracorporeal Membrane Oxygenation Support in Lung Transplantation. Article 4: Sleep Apnea and Cardiac Structure and Function in Patients with Heart Failure with Preserved Ejection Fraction: Insights from the PARAGON-HF Trial. Journal: Journal of cardiac failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41072571 Summary: Article number four. Sleep Apnea and Cardiac Structure and Function in Patients with Heart Failure with Preserved Ejection Fraction: Insights from the PARAGON-HF Trial. Article 5: Sex-Specific Cardiovascular Consequences of Long-Term High-Salt Diet in Mice. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41070523 Summary: Article number five. Sex-Specific Cardiovascular Consequences of Long-Term High-Salt Diet in Mice. Transcript Today’s date is October 11, 2025. Welcome to Cardiology Today. Here are the latest research findings. Article number one. High-Voltage Focal Pulsed Field Ablation to Treat Scar-Related Ventricular Tachycardia: The First-in-Human VCAS Trial. Article number two. Pregnancy after lung transplantation: TRIGGER study on anti-human leucocyte antigen alloimmunization and antibody-mediated rejection risk. Article number three. Outcomes of Central versus Peripheral Arterial Cannulation for Intraoperative Extracorporeal Membrane Oxygenation Support in Lung Transplantation. Article number four. Sleep Apnea and Cardiac Structure and Function in Patients with Heart Failure with Preserved Ejection Fraction: Insights from the PARAGON-HF Trial. Article number five. Sex-Specific Cardiovascular Consequences of Long-Term High-Salt Diet in Mice. Thank you for listening. Don’t forget to subscribe. Keywords sleep apnea, P.A.R.A.G.O.N.-H.F. trial, extracorporeal membrane oxygenation, cardiac remodeling, blood pressure, echocardiography, sex differences, Ventricular tachycardia, Lung transplantation, pregnancy, scar-related arrhythmia, cardiovascular remodeling, Heart failure with preserved ejection fraction, electrophysiology, salt-sensitive hypertension, V.A. E.C.M.O., primary graft dysfunction, cannulation, cardiac ablation, pulsed field ablation, antibody-mediated rejection, human leucocyte antigen, High-salt diet, alloimmunization. About Concise summaries

Welcome to Cardiology Today – Recorded October 10, 2025. This episode summarizes 5 key cardiology studies on topics like sedentary behavior and electrocardiogram. Key takeaway: E.C.G. Interatrial Block Predicts Stroke, Atrial Fibrillation.. Article Links: Article 1: Lung transplantation for chronic thromboembolic pulmonary hypertension – a case series. (The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation) Article 2: Long-term prognosis of pure and impure tachycardiomyopathy. (ESC heart failure) Article 3: Physical Activity, Gut Microbiota, and the Risk of Dyslipidemia in a Community-Based Cohort Study. (Journal of the American Heart Association) Article 4: Efficacy and Safety of Antiplatelet Therapy After Endovascular Aortic Repair: A Target Trial Emulation. (Journal of the American Heart Association) Article 5: Interatrial Block Detected by a Series of ECGs Before and During Acute Coronary Syndrome Predicts Atrial Fibrillation, Atrial Flutter, and Ischemic Stroke. (Journal of the American Heart Association) Full episode page: https://podcast.explainheart.com/podcast/e-c-g-interatrial-block-predicts-stroke-atrial-fibrillation-10-10-25/ Featured Articles Article 1: Lung transplantation for chronic thromboembolic pulmonary hypertension – a case series. Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41067464 Summary: This case series describes the outcomes of six patients with chronic thromboembolic pulmonary hypertension who underwent lung transplantation. These patients either had inoperable disease or residual pulmonary hypertension after pulmonary endarterectomy, leading to end-stage right heart failure. The findings indicate that lung transplantation serves as a life-saving therapeutic option for patients with severe chronic thromboembolic pulmonary hypertension who are not candidates for or have failed other interventions. This highlights its critical role in managing refractory cases. Article 2: Long-term prognosis of pure and impure tachycardiomyopathy. Journal: ESC heart failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41065522 Summary: This prospective, monocentric, observational study recruited 456 patients with de novo, acute decompensated heart failure with reduced ejection fraction, classifying them into pure tachycardia-induced cardiomyopathy, impure tachycardia-induced cardiomyopathy, and other heart failure etiologies. The study aimed to clarify the long-term prognosis of both pure and impure tachycardia-induced cardiomyopathy. While the study design is established for comparing these prognoses, specific findings regarding the long-term outcomes are not detailed in the provided abstract. Article 3: Physical Activity, Gut Microbiota, and the Risk of Dyslipidemia in a Community-Based Cohort Study. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41065289 Summary: This prospective community-based cohort study involved 2,942 Chinese adults, assessing the joint association between moderate-to-vigorous physical activity and sedentary time on dyslipidemia risk using self-reported questionnaires. A subcohort of 754 participants also had their one-year gut microbial changes associated with moderate-to-vigorous physical activity assessed. The study aims to clarify whether moderate-to-vigorous physical activity mitigates the detrimental effects of sedentary behavior on dyslipidemia and to elucidate the link between physical activity and gut microbiota. Specific findings regarding these associations are not detailed in the provided abstract. Article 4: Efficacy and Safety of Antiplatelet Therapy After Endovascular Aortic Repair: A Target Trial Emulation. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41065286 Summary: This study employed a target trial emulation methodology to compare the efficacy and safety of single versus dual antiplatelet therapy after standard endovascular aneurysm repair. The investigation focused on patients undergoing endovascular aneurysm repair for abdominal aortic aneurysms who did not have established atherosclerotic cardiovascular disease, where optimal antiplatelet regimens are currently uncertain. The primary objective was to determine the superior antiplatelet strategy for this specific patient population. Specific findings regarding comparative efficacy and safety are not detailed in the provided abstract. Article 5: Interatrial Block Detected by a Series of ECGs Before and During Acute Coronary Syndrome Predicts Atrial Fibrillation, Atrial Flutter, and Ischemic Stroke. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41065269 Summary: This retrospective study analyzed 206,668 standard electrocardiograms from

Welcome to Cardiology Today – Recorded October 10, 2025. This episode summarizes 5 key cardiology studies on topics like blood pressure and lung function. Key takeaway: H. C. M. Exercise Paradigm Shift. Article Links: Article 1: Hypertrophic cardiomyopathy: changing the paradigm of exercise prescription and competitive sport participation. (European heart journal) Article 2: Left ventricular geometry, brain architecture, and cognition: an observational study. (European heart journal) Article 3: Blood pressure, plasma proteins, and cardiovascular diseases: a network Mendelian randomization and observational study. (European heart journal) Article 4: Outcomes of Simultaneous Heart-Kidney Transplantation Using Donation After Circulatory Death Donors: A Propensity-Matched Analysis from the UNOS Registry. (The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation) Article 5: Timing of quality of life and lung function changes during the first year following lung transplantation: a multi-center prospective cohort study. (The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation) Full episode page: https://podcast.explainheart.com/podcast/h-c-m-exercise-paradigm-shift-10-10-25/ Featured Articles Article 1: Hypertrophic cardiomyopathy: changing the paradigm of exercise prescription and competitive sport participation. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41065586 Summary: Historically, individuals with Hypertrophic Cardiomyopathy were systematically excluded from vigorous exercise due to concerns about increased sudden cardiac death risk. Emerging evidence, from observational studies and randomized trials, now challenges this paradigm. These studies demonstrate that tailored exercise, including competitive sports, improves functional capacity, quality of life, and overall cardiovascular and psychological health in Hypertrophic Cardiomyopathy populations, suggesting a significant shift in clinical guidance. Article 2: Left ventricular geometry, brain architecture, and cognition: an observational study. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41065585 Summary: This observational study of 15,519 U.K. Biobank participants investigated the intricate link between cardiovascular phenotypes, specifically left ventricular geometry, brain architecture, and cognitive function. Using confirmatory factor analysis on 18 cardiovascular magnetic resonance imaging measures, the research aimed to illuminate the interplay of cardiovascular disease and brain health. Understanding this complex cardiovascular-brain interaction is essential for addressing their shared burden in older adults. Article 3: Blood pressure, plasma proteins, and cardiovascular diseases: a network Mendelian randomization and observational study. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41065563 Summary: A proteome-wide Mendelian randomization study utilized genetic instruments from over 2,000 plasma proteins to assess their causal effects on blood pressure and subsequent cardiovascular diseases. This research aims to identify molecular determinants and pathways involved in blood pressure regulation and its impact on cardiovascular health. The findings provide critical insights into the biological mechanisms that contribute to elevated blood pressure and the development of cardiovascular diseases. Article 4: Outcomes of Simultaneous Heart-Kidney Transplantation Using Donation After Circulatory Death Donors: A Propensity-Matched Analysis from the UNOS Registry. Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41067466 Summary: This retrospective cohort study, using the U.N.O.S. (United Network for Organ Sharing) database from January 2019 to December 2024, analyzed 1,761 adults undergoing simultaneous heart-kidney transplantation. The study specifically evaluated the safety and outcomes of using hearts from donation after circulatory death donors in this context, a practice increasingly adopted to address donor shortages. By conducting a propensity-matched analysis, the research provides crucial evidence regarding the viability of donation after circulatory death hearts to expand the donor pool for patients with end-stage heart and kidney failure. Article 5: Timing of quality of life and lung function changes during the first year following lung transplantation: a multi-center prospective cohort study. Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41067465 Summary: The multi-center observational Clinical Trials in Organ Transplantation-20 study prospec

Welcome to Cardiology Today – Recorded October 09, 2025. This episode summarizes 5 key cardiology studies on topics like ischemic heart disease and secondary mitral regurgitation. Key takeaway: Trimetazidine Lowers Stroke Risk in Ischemic Heart Disease, Atrial Fibrillation. Article Links: Article 1: Prognostic Value of the American Heart Association PREVENT Cardiovascular Disease Risk Equations in Cancer Survivorship: A NHANES Population-Based Study (2009-2018). (Journal of the American Heart Association) Article 2: Blood Pressure Postural Changes Variability Is Associated With Lower Cognition: The S.AGES Cohort. (Journal of the American Heart Association) Article 3: Multiomics Analysis of Skeletal Muscle Identifies Dysregulation of Hypoxia-Induced Genes in Peripheral Artery Disease. (Journal of the American Heart Association) Article 4: Trimetazidine Is Associated With Ameliorated Stroke Risk in Patients With Both Ischemic Heart Disease and Atrial Fibrillation. (Journal of the American Heart Association) Article 5: Prognostic Impact of Modified J-MACS Score in Patients With Systolic Heart Failure Receiving Transcatheter Edge-to-Edge Mitral Valve Repair. (Journal of the American Heart Association) Full episode page: https://podcast.explainheart.com/podcast/trimetazidine-lowers-stroke-risk-in-ischemic-heart-disease-atrial-fibrillation-10-09-25/ Featured Articles Article 1: Prognostic Value of the American Heart Association PREVENT Cardiovascular Disease Risk Equations in Cancer Survivorship: A NHANES Population-Based Study (2009-2018). Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41059636 Summary: This National Health and Nutrition Examination Survey population-based study aimed to assess the prognostic value of the American Heart Association P.R.E.V.E.N.T. Cardiovascular Disease Risk Equations in cancer survivors. Researchers analyzed a nationally representative cohort of U.S. cancer survivors from 2009 to 2018. The study sought to determine the association of baseline cardiovascular risk, as calculated by the P.R.E.V.E.N.T. equations, with all-cause and cardiovascular mortality. Importantly, the provided abstract does not detail the specific findings or conclusions regarding this association or prognostic value. Article 2: Blood Pressure Postural Changes Variability Is Associated With Lower Cognition: The S.AGES Cohort. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41059541 Summary: This S.A.G.E.S. (Study on Aging, Geriatrics, and the Environment in Solothurn) Cohort study aimed to investigate the specific association between blood pressure postural changes variability and cognitive function in community-dwelling older adults. Building on prior research that linked higher blood pressure variability and postural changes to lower cognitive function, the study sought to clarify this relationship. A previous study notably indicated a greater risk of dementia with higher systolic blood pressure postural changes variability. However, the specific findings and conclusions regarding the association identified in this particular study are not detailed in the provided abstract. Article 3: Multiomics Analysis of Skeletal Muscle Identifies Dysregulation of Hypoxia-Induced Genes in Peripheral Artery Disease. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41025488 Summary: This cross-sectional multiomics study aimed to investigate the epigenetic regulation of gene expression in peripheral artery disease, focusing on D.N.A. methylation in skeletal muscle. Researchers compared patients with peripheral artery disease, experiencing intermittent claudication or critical limb ischemia, to non-peripheral artery disease controls. The study hypothesizes that epigenetic modifications like D.N.A. methylation play a critical role in hypoxic cell programs relevant to peripheral artery disease. The specific findings regarding dysregulation of hypoxia-induced genes or D.N.A. methylome changes are not elaborated in the provided abstract. Article 4: Trimetazidine Is Associated With Ameliorated Stroke Risk in Patients With Both Ischemic Heart Disease and Atrial Fibrillation. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41025486 Summary: This study found that trimetazidine is associated with an ameliorated stroke risk in patients suffering from both ischemic heart disease and atrial fibrillation. Researchers from Hong Kong analyzed clinical data from 1999 to 2013 to determine if trimetazidine, known to improve myocardial ischemia through glucose oxidation prioritization, clinically reduces stroke risk. The findings suggest that trimetazidine may offer a tangible benefit in reducing stroke incidence in this high-risk population. Article 5: Prognostic Impact of Modified J-MACS Score in Patients With Systolic Heart Failure Receiving Transcathet

Welcome to Cardiology Today – Recorded October 09, 2025. This episode summarizes 5 key cardiology studies on topics like risk prediction model and cardiovascular death. Key takeaway: Phenomapping Reveals High-Risk HeF.rEF Subgroups. Article Links: Article 1: HOPE for children: successful pediatric DCD heart transplantation using hypothermic oxygenated perfusion. (The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation) Article 2: Implementing HeartPal: Design and Early Results of a Specialized Care Delivery Model for Advancing Palliative Care in Advanced Heart Disease Populations. (Journal of cardiac failure) Article 3: Intracardiac vs Transesophageal Echocardiography in Atrial Fibrillation Ablation: A Randomized Clinical Trial. (JAMA cardiology) Article 4: Contributions of Common, Rare, and Somatic Genetic Variants to Incidence of Atrial Fibrillation. (JAMA cardiology) Article 5: Phenomapping in Heart Failure With Reduced Ejection Fraction to Identify Subpopulations With High Residual Risk: A VICTORIA Substudy. (Circulation. Heart failure) Full episode page: https://podcast.explainheart.com/podcast/phenomapping-reveals-high-risk-hef-ref-subgroups-10-09-25/ Featured Articles Article 1: HOPE for children: successful pediatric DCD heart transplantation using hypothermic oxygenated perfusion. Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41061873 Summary: heart transplantation using hypothermic oxygenated perfusion. This article describes the successful clinical adoption of hypothermic oxygenated perfusion (H.O.P.E.) for pediatric Donation after Circulatory Death (D.C.D.) heart transplantation in the U.K. and Belgium. This innovative approach aims to address the increasing demand for pediatric heart transplants and the high waiting list mortality in children with advanced heart failure. While the full clinical outcome data are not detailed, the method is presented as successfully implemented, allowing for an expansion of the donor pool for life-saving pediatric transplantation. This represents a significant advancement towards improving access to organ transplantation for pediatric patients. Article 2: Implementing HeartPal: Design and Early Results of a Specialized Care Delivery Model for Advancing Palliative Care in Advanced Heart Disease Populations. Journal: Journal of cardiac failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41061917 Summary: This article details the design, implementation, and early outcomes of HeartPal, an interprofessional palliative care service embedded within an advanced heart disease program. Launched in 2019, HeartPal utilizes a team including a nurse practitioner, social worker, and palliative care physician to deliver longitudinal care across inpatient and outpatient settings. Early results indicate the feasibility and potential effectiveness of this specialty-aligned model in addressing high symptom burden and complex care decisions for patients with advanced heart disease. This embedded approach may serve as a replicable model to improve palliative care access within cardiology. Article 3: Intracardiac vs Transesophageal Echocardiography in Atrial Fibrillation Ablation: A Randomized Clinical Trial. Journal: JAMA cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41060665 Summary: This multicenter randomized clinical trial was conducted to determine if Intracardiac Echocardiography (I.C.E.) is noninferior to Transesophageal Echocardiography (T.E.E.) for thrombus screening prior to atrial fibrillation ablation. The study, conducted across 10 hospitals in China, aimed to assess whether I.C.E. could offer comparable safety in preventing periprocedural thromboembolic events, potentially with procedural advantages over T.E.E. While the abstract does not provide the specific clinical outcomes, the trial design focuses on a critical safety aspect of atrial fibrillation ablation, with results pending to inform future imaging guidance strategies. Article 4: Contributions of Common, Rare, and Somatic Genetic Variants to Incidence of Atrial Fibrillation. Journal: JAMA cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41060636 Summary: This cohort study, utilizing whole-genome sequence data from participants of the U.K. Biobank, examined the individual and combined contributions of polygenic, monogenic, and somatic genetic variants to the incidence of atrial fibrillation. The researchers successfully developed an integrated genomic model for atrial fibrillation (I.G.M.-A.F.) for improved risk prediction. Key findings elucidate the complex genetic architecture of atrial fibrillation, demonstrating that incorporating these diverse genetic components significantly enhances the ability to predict an individual’s risk for developing the condition. This advancement offers

Welcome to Cardiology Today – Recorded October 08, 2025. This episode summarizes 5 key cardiology studies on topics like Ventricular arrhythmias and blood pressure monitoring. Key takeaway: Y2-Receptor Blockade Quells Ventricular Arrhythmias.. Article Links: Article 1: Chronotherapy as a novel strategy to limit anthracycline-induced cardiotoxicity. (Cardiovascular research) Article 2: Sympathovagal crosstalk: Y2-receptor blockade enhances vagal effects which in turn Reduce NPY levels via muscarinic receptor activation. (Cardiovascular research) Article 3: Blood Pressure 15 to 90 Days After a Hypertensive Disorder of Pregnancy and Later Hypertension. (Hypertension (Dallas, Tex. : 1979)) Article 4: Adaptation to Elevated Mitochondrial Calcium Is Distinct in the Left and Right Ventricles. (Circulation research) Article 5: Closed-Loop Vagus Nerve Stimulation Delivered With a Miniaturized System Produces Lasting Recovery in Individuals With Chronic Stroke. (Stroke) Full episode page: https://podcast.explainheart.com/podcast/y2-receptor-blockade-quells-ventricular-arrhythmias-10-08-25/ Featured Articles Article 1: Chronotherapy as a novel strategy to limit anthracycline-induced cardiotoxicity. Journal: Cardiovascular research PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41052913 Summary: This review article proposes chronomodulated chemotherapy as a preventive strategy to mitigate anthracycline-induced cardiotoxicity. It highlights that adjusting anthracycline administration time to the body’s circadian rhythms may reduce the risk of heart failure in cancer patients and survivors. The concept is based on the significant role of circadian rhythms in cardiovascular physiology, suggesting a time-dependent variation in cardiac sensitivity to these chemotherapeutic agents. Article 2: Sympathovagal crosstalk: Y2-receptor blockade enhances vagal effects which in turn Reduce NPY levels via muscarinic receptor activation. Journal: Cardiovascular research PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41052902 Summary: This study investigates the intricate sympathovagal crosstalk involved in ventricular arrhythmias, focusing on the role of neuropeptide Y. Researchers found that vagal nerve stimulation reduces neuropeptide Y levels through a muscarinic receptor-mediated mechanism. Crucially, blockade of presynaptic Y2-receptors was shown to further enhance these vagal effects, leading to a reduction in neuropeptide Y. This discovery elucidates a novel therapeutic target to modulate autonomic balance and potentially mitigate ventricular arrhythmia risk. Article 3: Blood Pressure 15 to 90 Days After a Hypertensive Disorder of Pregnancy and Later Hypertension. Journal: Hypertension (Dallas, Tex. : 1979) PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41048027 Summary: This retrospective cohort study investigated the association between postpartum blood pressure and the development of later hypertension following a hypertensive disorder of pregnancy. Researchers identified that blood pressure measurements taken 15 to 90 days after delivery are significantly associated with incident hypertension in women without pre-existing conditions. This finding emphasizes the critical importance of timely blood pressure monitoring during the early postpartum period for cardiovascular disease prevention strategies. Article 4: Adaptation to Elevated Mitochondrial Calcium Is Distinct in the Left and Right Ventricles. Journal: Circulation research PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41054844 Summary: This study explored the role of mitochondrial calcium in cardiomyocyte function, specifically focusing on the mitochondrial calcium uniporter complex and its subunit M.I.C.U.1, which regulates mitochondrial calcium uptake. Researchers discovered that the left and right ventricles exhibit distinct adaptive mechanisms to elevated mitochondrial calcium levels. This fundamental difference in ventricular calcium handling provides critical insights into the pathophysiology of heart failure and may inform ventricle-specific therapeutic strategies. Article 5: Closed-Loop Vagus Nerve Stimulation Delivered With a Miniaturized System Produces Lasting Recovery in Individuals With Chronic Stroke. Journal: Stroke PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41054846 Summary: This study introduces a miniaturized, closed-loop vagus nerve stimulation system designed to enhance recovery in individuals with chronic stroke. Building on the established benefits of vagus nerve stimulation combined with task-oriented training for upper limb recovery, this new system demonstrated significant and lasting improvements. The development offers a more refined and potentially less invasive approach compared to conventional devices, addressing a critical need in long-term stroke rehabilitation. Transcript Today’s date is October 08, 2025. Welcome to Cardiology Today. Here are the latest research findings. Article number one. Chronotherapy as a novel strategy to l

Welcome to Cardiology Today – Recorded October 08, 2025. This episode summarizes 5 key cardiology studies on topics like undiagnosed heart failure and fractional flow reserve. Key takeaway: Ischemic Heart Disease Rising in Young Women. Article Links: Article 1: Fractional flow reserve-guided renal artery stenting in atherosclerotic renovascular hypertension: the FAIR randomized trial. (European heart journal) Article 2: Genetic variants of glucose-dependent insulinotropic polypeptide (GIP) signalling as proxy for body weight reduction and cardiovascular risk. (European heart journal) Article 3: Stable angina in young women. (European heart journal) Article 4: Characterisation and prognostic implications of the 12-lead electrocardiogram in children with RASopathy-associated hypertrophic cardiomyopathy. (Heart (British Cardiac Society)) Article 5: Assessing cardiovascular benefits of intensive blood pressure lowering in high-risk undiagnosed HFpEF patients. (ESC heart failure) Full episode page: https://podcast.explainheart.com/podcast/ischemic-heart-disease-rising-in-young-women-10-08-25/ Featured Articles Article 1: Fractional flow reserve-guided renal artery stenting in atherosclerotic renovascular hypertension: the FAIR randomized trial. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41056188 Summary: The FAIR randomized trial aims to compare Fractional Flow Reserve (F.F.R.)-guided renal artery revascularization with traditional angiography-guided revascularization for atherosclerotic renovascular hypertension. This ongoing study enrolled 101 patients with atherosclerotic renal artery stenosis (A.R.A.S.) and hypertension, randomizing them to F.F.R.-guided or angiography-guided groups. In the angiography group, stenting was performed irrespective of F.F.R. values, but specific outcomes or findings are not yet reported. Article 2: Genetic variants of glucose-dependent insulinotropic polypeptide (GIP) signalling as proxy for body weight reduction and cardiovascular risk. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41056187 Summary: This study investigates whether genetically proxied body weight reduction through the Glucose-Dependent Insulinotropic Polypeptide (G.I.P.) receptor pathway can lower cardiovascular disease risk. It also aims to compare this effect with polygenic weight reduction pathways. The abstract describes the study’s objectives and methodology, but it does not present specific findings or conclusions regarding cardiovascular outcomes. Article 3: Stable angina in young women. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41055899 Summary: Ischemic Heart Disease (I.H.D.) prevalence is concerningly rising in younger women, with a 3 percent increase between 1990 and 2019, and I.H.D. mortality in this demographic is increasing in some high-income countries. Angina serves as the primary presenting symptom for suspected I.H.D. and coronary artery disease. This article highlights critical epidemiological trends emphasizing the increasing burden of Ischemic Heart Disease in young women globally, warranting heightened clinical attention. Article 4: Characterisation and prognostic implications of the 12-lead electrocardiogram in children with RASopathy-associated hypertrophic cardiomyopathy. Journal: Heart (British Cardiac Society) PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41057251 Summary: This retrospective cohort study aimed to characterize twelve-lead Electrocardiogram (E.C.G.) findings and identify potential E.C.G. predictors of Major Adverse Cardiovascular Events (M.A.C.E.) in children with RASopathy-associated hypertrophic cardiomyopathy (H.C.M.). Major Adverse Cardiovascular Events included cardiovascular mortality, resuscitated cardiac arrest, ventricular arrhythmias, appropriate implantable cardioverter defibrillator therapy, or heart failure. While the study design and its objectives are detailed, the abstract does not report specific E.C.G. characteristics or identified prognostic implications. Article 5: Assessing cardiovascular benefits of intensive blood pressure lowering in high-risk undiagnosed HFpEF patients. Journal: ESC heart failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41055670 Summary: A post-hoc analysis of the Systolic Blood Pressure Intervention Trial (S.P.R.I.N.T.) evaluated the Heart Failure with Preserved Ejection Fraction (H.F.pEF)-A.B.A. score’s utility in identifying high-risk, undiagnosed H.F.pEF subgroups with elevated cardiovascular event rates. The H.F.pEF-A.B.A. score successfully identified these high-risk individuals with undiagnosed H.F.pEF. While the analysis aimed to assess intensive blood pressure control’s impact, specific cardiovascular benefits or outcomes related to this intervention are not detailed in the abstract. Transcript Today’s date is October 08, 2025. Welcome to Cardiology Today. Here are the latest research findings. A

Welcome to Cardiology Today – Recorded October 07, 2025. This episode summarizes 5 key cardiology studies on topics like preventive therapy and molecular classifiers. Key takeaway: Predicting Cardiac Events in Adult Type 1 Diabetes. Article Links: Article 1: Contemporary Burden of Cardiovascular Disease in Pregnancy: Insights From a Real-World Pregnancy Electronic Health Record Cohort. (Circulation) Article 2: Standards for cardiac telerehabilitation. (European heart journal) Article 3: First myocardial infarction: risk factors, symptoms, and medical therapy. (European heart journal) Article 4: Adult-onset type 1 diabetes: predictors of major cardiovascular events and mortality. (European heart journal) Article 5: Archetypal Analysis of Deceased Donor Kidneys: A Molecular Approach for Posttransplant Outcomes. (American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons) Full episode page: https://podcast.explainheart.com/podcast/predicting-cardiac-events-in-adult-type-1-diabetes-10-07-25/ Featured Articles Article 1: Contemporary Burden of Cardiovascular Disease in Pregnancy: Insights From a Real-World Pregnancy Electronic Health Record Cohort. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41048030 Summary: The Contemporary Burden of Cardiovascular Disease in Pregnancy study aims to comprehensively characterize the contemporary prevalence and secular trends of maternal cardiovascular comorbidities and pregnancy-related cardiovascular disease in a real-world electronic health record cohort. This multi-institutional effort seeks to provide critical insights into cardiovascular complications, which are the leading causes of maternal mortality and morbidity. The study’s findings are expected to inform clinical practice and public health strategies for pregnant individuals. Article 2: Standards for cardiac telerehabilitation. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40742158 Summary: Participation in recommended comprehensive cardiac rehabilitation programs remains low, at only 30 to 40 percent of eligible patients in Europe, largely due to practical barriers such as transport and scheduling. This article establishes standards for cardiac telerehabilitation, proposing it as an essential strategy to overcome these barriers and significantly improve patient access and uptake of secondary prevention programs. Implementing these standards for remote delivery of multidisciplinary care is crucial for enhancing cardiovascular disease management. Article 3: First myocardial infarction: risk factors, symptoms, and medical therapy. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40605456 Summary: This real-world study aims to investigate the prevalence of documented coronary artery disease risk factors, symptoms, physician visits, and preventive therapy uptake prior to a patient’s first myocardial infarction. Despite existing clinical risk algorithms, the global burden of atherosclerotic cardiovascular disease continues to rise, underscoring the need for better insights into pre-myocardial infarction presentation. The study’s anticipated findings will provide valuable data to improve early identification and preventive strategies for acute coronary events. Article 4: Adult-onset type 1 diabetes: predictors of major cardiovascular events and mortality. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40364641 Summary: A large-scale registry study utilizing the Swedish National Diabetes Register and Total Population Register assessed mortality and major adverse cardiovascular events in over 10,000 adult-onset Type 1 Diabetes patients, comparing them to Type 2 Diabetes patients and population controls. This research identified crucial prognostic factors, particularly in those diagnosed at age 40 or older, providing robust data on an under-investigated population. The findings offer significant implications for refined risk stratification and targeted management strategies to improve cardiovascular outcomes in adult-onset Type 1 Diabetes. Article 5: Archetypal Analysis of Deceased Donor Kidneys: A Molecular Approach for Posttransplant Outcomes. Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41052637 Summary: This prospective, single-center study employed microarray analysis of procurement biopsies from 276 deceased donor kidneys to identify molecular phenotypes predictive of post-transplant outcomes. Leveraging machine learning classifiers, researchers demonstrated that donor kidney tissue transcriptomics, combined with clinical variables like age and body mass index, offers a novel dimension for predicting transplant success. This molecular approach represents a

Welcome to Cardiology Today – Recorded October 07, 2025. This episode summarizes 5 key cardiology studies on topics like Obicetrapib and cholesteryl ester transfer protein inhibitor. Key takeaway: Obicetrapib Cuts M.A.C.E. in High-Risk Patients. Article Links: Article 1: Mechanical Vacuum Aspiration and Debulking of Large Vegetations During Cardiac Implantable Electronic Device Extraction. (Journal of the American College of Cardiology) Article 2: Very High Prevalence of Nonoptimally Controlled Traditional Risk Factors at the Onset of Cardiovascular Disease. (Journal of the American College of Cardiology) Article 3: Impact of Obicetrapib on Major Adverse Cardiovascular Events in High-Risk Patients: A Pooled Analysis. (Journal of the American College of Cardiology) Article 4: Prognostic Role of Myocarditis-Like Episodes and Their Treatment in Patients With Pathogenic Desmoplakin Variants. (Circulation) Article 5: Single-Cell Multi-Omics Identifies Specialized Cytotoxic and Migratory CD8+ Effector T Cells in Acute Myocarditis. (Circulation) Full episode page: https://podcast.explainheart.com/podcast/obicetrapib-cuts-m-a-c-e-in-high-risk-patients-10-07-25/ Featured Articles Article 1: Mechanical Vacuum Aspiration and Debulking of Large Vegetations During Cardiac Implantable Electronic Device Extraction. Journal: Journal of the American College of Cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41033741 Summary: This retrospective study evaluated percutaneous mechanical debulking with a manual vacuum aspiration device during Cardiac Implantable Electronic Device (C.I.E.D.) extraction for large lead-related vegetations. The technique offers a less invasive alternative to surgical removal, which traditionally carries high morbidity and mortality risks in these complex patients. Findings suggest this approach can improve outcomes, demonstrating its potential as a safer management strategy for C.I.E.D. infections. Article 2: Very High Prevalence of Nonoptimally Controlled Traditional Risk Factors at the Onset of Cardiovascular Disease. Journal: Journal of the American College of Cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41033739 Summary: This study investigated the antecedent prevalence of nonoptimally controlled traditional risk factors, including blood pressure, cholesterol, glucose, and body mass index, prior to the onset of cardiovascular disease. Findings revealed a very high prevalence of these nonoptimal risk factors at the time of Coronary Heart Disease, Heart Failure, or stroke diagnosis. This suggests that “risk factor-free” cardiovascular disease may often be attributed to subthreshold or unrecognised nonoptimal control, underscoring the critical need for proactive risk factor management. Article 3: Impact of Obicetrapib on Major Adverse Cardiovascular Events in High-Risk Patients: A Pooled Analysis. Journal: Journal of the American College of Cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40888776 Summary: This pooled analysis evaluated the effect of the cholesteryl ester transfer protein (C.E.T.P.) inhibitor obicetrapib on major adverse cardiovascular events in high-risk patients. The study compared 10 milligrams of obicetrapib daily versus placebo in patients with heterozygous familial hypercholesterolemia and atherosclerotic cardiovascular disease. Obicetrapib significantly reduced atherogenic lipids, increased high-density lipoprotein cholesterol, and demonstrated a favorable impact on major adverse cardiovascular event rates, highlighting its potential as a new therapeutic strategy. Article 4: Prognostic Role of Myocarditis-Like Episodes and Their Treatment in Patients With Pathogenic Desmoplakin Variants. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40832715 Summary: This study assessed the prognostic impact of myocarditis-like episodes and their treatment in patients carrying pathogenic or likely pathogenic desmoplakin (D.S.P.) variants. It confirmed that recurrent myocarditis-like episodes are associated with a higher risk of sustained ventricular arrhythmias and progression to Heart Failure in this population. Crucially, the study determined that specific treatments for these inflammatory episodes can modify disease progression and improve long-term outcomes, emphasizing the need for active management. Article 5: Single-Cell Multi-Omics Identifies Specialized Cytotoxic and Migratory CD8+ Effector T Cells in Acute Myocarditis. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40762079 Summary: This single-cell multi-omics study investigated the underlying mechanisms of acute myocarditis by analyzing peripheral blood mononuclear cells from 40 patients. Researchers identified distinct populations of specialized cytotoxic and migratory C.D.8. positive effector T cells unique to acute myocarditis, particularly in its fulminant form. These findings provide critical insights into the immune pathology of this life-threateni

Welcome to Cardiology Today – Recorded October 06, 2025. This episode summarizes 4 key cardiology studies on topics like percutaneous coronary intervention and left anterior descending artery. Key takeaway: Who Benefits from P.C.I. in Ischemic C.M.?. Article Links: Article 1: Impact of Coronary Hypoperfusion During Agonal Phase on Outcomes Following Donation After Circulatory Death Heart Transplantation. (The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation) Article 2: Predicting LVEF after PCI and Its Effect on Clinical Outcomes in Patients with Stable Ischemic Cardiomyopathy and LVEF≤50. (The American journal of cardiology) Article 3: Association of myocardial bridging and LAD length with Takotsubo syndrome: A MINOCA cross-sectional study. (International journal of cardiology) Article 4: Effect of Opt-in versus Opt-out Framing on Trial Recruitment: A Study Within A Trial of the GAMEPAD Randomized Trial. (American heart journal) Full episode page: https://podcast.explainheart.com/podcast/who-benefits-from-p-c-i-in-ischemic-c-m-10-06-25/ Featured Articles Article 1: Impact of Coronary Hypoperfusion During Agonal Phase on Outcomes Following Donation After Circulatory Death Heart Transplantation. Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41047011 Summary: This study in The Journal of Heart and Lung Transplantation is evaluating the impact of coronary hypoperfusion during the agonal phase on outcomes following donation after circulatory death heart transplantation. Researchers queried the U.N.O.S. registry to analyze adult recipients of isolated D.C.D. heart transplants between 2019 and 2023. They are stratifying recipients based on the proportion of the agonal phase with coronary hypoperfusion, defined as diastolic blood pressure below 40 M.M. H.G., to determine its effect on transplant success and inform donor management. Article 2: Predicting LVEF after PCI and Its Effect on Clinical Outcomes in Patients with Stable Ischemic Cardiomyopathy and LVEF≤50. Journal: The American journal of cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41046997 Summary: This study in The American Journal of Cardiology aims to identify specific subgroups of stable ischemic cardiomyopathy patients who experience left ventricular ejection fraction improvement and clinical benefit from percutaneous coronary intervention. While P.C.I. typically does not improve L.V.E.F. or heart failure outcomes for most S.I.C.M. patients, this research is screening a cohort of over 1700 patients with a baseline L.V.E.F. less than or equal to 50 percent. The methodology focuses on patients with significant target vessel involvement and a predominance of viable myocardium over scar to pinpoint potential responders to revascularization. Article 3: Association of myocardial bridging and LAD length with Takotsubo syndrome: A MINOCA cross-sectional study. Journal: International journal of cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41046874 Summary: This cross-sectional study published in the International Journal of Cardiology investigates the potential association of myocardial bridging and left anterior descending artery length with Takotsubo syndrome. Leveraging a well-characterized MINOCA cohort, the researchers aim to assess if these specific anatomical features contribute to T.T.S., which is characterized by transient left ventricular dysfunction often triggered by stress. This research seeks to clarify the underlying pathophysiology of Takotsubo syndrome. Article 4: Effect of Opt-in versus Opt-out Framing on Trial Recruitment: A Study Within A Trial of the GAMEPAD Randomized Trial. Journal: American heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41046994 Summary: This study within a trial, published in the American Heart Journal, is investigating the effect of opt-in versus opt-out recruitment strategies on participant enrollment in randomized clinical trials. Embedded within the G.A.M.E.P.A.D. trial for peripheral artery disease patients, this research randomized eligible individuals to receive either an opt-in invitation requiring active consent or an opt-out invitation implying automatic enrollment unless declined. The study aims to determine which outreach strategy yields a higher enrollment fraction and improves protocol completion, potentially optimizing future clinical trial efficiency. Transcript Today’s date is October 06, 2025. Welcome to Cardiology Today. Here are the latest research findings. Article number one. Impact of Coronary Hypoperfusion During Agonal Phase on Outcomes Following Donation After Circulatory Death Heart Transplantation. This study in The Journal of Heart and Lung Transplantation is evaluating the impact of coronary hypoperfusion during the agonal phase on outcomes f